<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>(#36) and #6</title>
    <link>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;v=2.17.6&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;utm_medium=rss&amp;ff=20220524175129&amp;utm_source=Other</link>
    <description>(#36) and #6: Latest results from PubMed</description>
    <atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;v=2.17.6&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;utm_medium=rss&amp;ff=20220524175129&amp;utm_source=Other" rel="self"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>PubMed RSS feeds (2.17.6)</generator>
    <language>en</language>
    <lastBuildDate>Tue, 24 May 2022 21:51:30 +0000</lastBuildDate>
    <pubDate>Tue, 24 May 2022 06:00:00 -0400</pubDate>
    <ttl>120</ttl>
    <item>
      <title>Neurodevelopmental Therapy for Cerebral Palsy: A Meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35607928/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: We found that activity-based and body structure and function interventions are more effective than NDT for improving motor function, NDT is no more effective than control, and higher-dose NDT is not more effective than lower-dose. Deimplementation of NDT in CP is required.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Pediatrics. 2022 May 24:e2021055061. doi: 10.1542/peds.2021-055061. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND OBJECTIVE: Bobath therapy, or neurodevelopmental therapy (NDT) is widely practiced despite evidence other interventions are more effective in cerebral palsy (CP). The objective is to determine the efficacy of NDT in children and infants with CP or high risk of CP.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Cumulative Index to Nursing and Allied Health Literature, Cochrane Library, Embase, and Medline were searched through March 2021. Randomized controlled trials comparing NDT with any or no intervention were included. Meta-analysis was conducted with standardized mean differences calculated. Quality was assessed by using Cochrane Risk of Bias tool-2 and certainty by using Grading of Recommendations Assessment, Development, and Evaluation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of 667 records screened, 34 studies (in 35 publications, 1332 participants) met inclusion. Four meta-analyses were conducted assessing motor function. We found no effect between NDT and control (pooled effect size 0.13 [-0.20 to 0.46]), a moderate effect favoring activity-based approaches (0.76 [0.12 to 1.40]) and body function and structures (0.77 [0.19 to 1.35]) over NDT and no effect between higher- and lower-dose NDT (0.32 [-0.11 to 0.75]). A strong recommendation against the use of NDT at any dose was made. Studies were not all Consolidated Standards of Reporting Trials-compliant. NDT versus activity-based comparator had considerable heterogeneity (I2 = 80%) reflecting varied measures.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: We found that activity-based and body structure and function interventions are more effective than NDT for improving motor function, NDT is no more effective than control, and higher-dose NDT is not more effective than lower-dose. Deimplementation of NDT in CP is required.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35607928/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35607928</a> | DOI:<a href=https://doi.org/10.1542/peds.2021-055061>10.1542/peds.2021-055061</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35607928</guid>
      <pubDate>Tue, 24 May 2022 06:00:00 -0400</pubDate>
      <dc:creator>Anna Te Velde</dc:creator>
      <dc:creator>Catherine Morgan</dc:creator>
      <dc:creator>Megan Finch-Edmondson</dc:creator>
      <dc:creator>Lynda McNamara</dc:creator>
      <dc:creator>Maria McNamara</dc:creator>
      <dc:creator>Madison Claire Badawy Paton</dc:creator>
      <dc:creator>Emma Stanton</dc:creator>
      <dc:creator>Annabel Webb</dc:creator>
      <dc:creator>Nadia Badawi</dc:creator>
      <dc:creator>Iona Novak</dc:creator>
      <dc:date>2022-05-24</dc:date>
      <dc:source>Pediatrics</dc:source>
      <dc:title>Neurodevelopmental Therapy for Cerebral Palsy: A Meta-analysis</dc:title>
      <dc:identifier>pmid:35607928</dc:identifier>
      <dc:identifier>doi:10.1542/peds.2021-055061</dc:identifier>
    </item>
    <item>
      <title>Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35593186/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>BACKGROUND: COVID-19 illness is highly variable, ranging from infection with no symptoms through to pneumonia and life-threatening consequences. Symptoms such as fever, cough, or loss of sense of smell (anosmia) or taste (ageusia), can help flag early on if the disease is present. Such information could be used either to rule out COVID-19 disease, or to identify people who need to go for COVID-19 diagnostic tests. This is the second update of this review, which was first published in 2020.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: COVID-19 illness is highly variable, ranging from infection with no symptoms through to pneumonia and life-threatening consequences. Symptoms such as fever, cough, or loss of sense of smell (anosmia) or taste (ageusia), can help flag early on if the disease is present. Such information could be used either to rule out COVID-19 disease, or to identify people who need to go for COVID-19 diagnostic tests. This is the second update of this review, which was first published in 2020.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: To assess the diagnostic accuracy of signs and symptoms to determine if a person presenting in primary care or to hospital outpatient settings, such as the emergency department or dedicated COVID-19 clinics, has COVID-19.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">SEARCH METHODS: We undertook electronic searches up to 10 June 2021 in the University of Bern living search database. In addition, we checked repositories of COVID-19 publications. We used artificial intelligence text analysis to conduct an initial classification of documents. We did not apply any language restrictions.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">SELECTION CRITERIA: Studies were eligible if they included people with clinically suspected COVID-19, or recruited known cases with COVID-19 and also controls without COVID-19 from a single-gate cohort. Studies were eligible when they recruited people presenting to primary care or hospital outpatient settings. Studies that included people who contracted SARS-CoV-2 infection while admitted to hospital were not eligible. The minimum eligible sample size of studies was 10 participants. All signs and symptoms were eligible for this review, including individual signs and symptoms or combinations. We accepted a range of reference standards.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DATA COLLECTION AND ANALYSIS: Pairs of review authors independently selected all studies, at both title and abstract, and full-text stage. They resolved any disagreements by discussion with a third review author. Two review authors independently extracted data and assessed risk of bias using the QUADAS-2 checklist, and resolved disagreements by discussion with a third review author. Analyses were restricted to prospective studies only. We presented sensitivity and specificity in paired forest plots, in receiver operating characteristic (ROC) space and in dumbbell plots. We estimated summary parameters using a bivariate random-effects meta-analysis whenever five or more primary prospective studies were available, and whenever heterogeneity across studies was deemed acceptable.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN RESULTS: We identified 90 studies; for this update we focused on the results of 42 prospective studies with 52,608 participants. Prevalence of COVID-19 disease varied from 3.7% to 60.6% with a median of 27.4%. Thirty-five studies were set in emergency departments or outpatient test centres (46,878 participants), three in primary care settings (1230 participants), two in a mixed population of in- and outpatients in a paediatric hospital setting (493 participants), and two overlapping studies in nursing homes (4007 participants). The studies did not clearly distinguish mild COVID-19 disease from COVID-19 pneumonia, so we present the results for both conditions together. Twelve studies had a high risk of bias for selection of participants because they used a high level of preselection to decide whether reverse transcription polymerase chain reaction (RT-PCR) testing was needed, or because they enrolled a non-consecutive sample, or because they excluded individuals while they were part of the study base. We rated 36 of the 42 studies as high risk of bias for the index tests because there was little or no detail on how, by whom and when, the symptoms were measured. For most studies, eligibility for testing was dependent on the local case definition and testing criteria that were in effect at the time of the study, meaning most people who were included in studies had already been referred to health services based on the symptoms that we are evaluating in this review. The applicability of the results of this review iteration improved in comparison with the previous reviews. This version has more studies of people presenting to ambulatory settings, which is where the majority of assessments for COVID-19 take place. Only three studies presented any data on children separately, and only one focused specifically on older adults. We found data on 96 symptoms or combinations of signs and symptoms. Evidence on individual signs as diagnostic tests was rarely reported, so this review reports mainly on the diagnostic value of symptoms. Results were highly variable across studies. Most had very low sensitivity and high specificity. RT-PCR was the most often used reference standard (40/42 studies). Only cough (11 studies) had a summary sensitivity above 50% (62.4%, 95% CI 50.6% to 72.9%)); its specificity was low (45.4%, 95% CI 33.5% to 57.9%)). Presence of fever had a sensitivity of 37.6% (95% CI 23.4% to 54.3%) and a specificity of 75.2% (95% CI 56.3% to 87.8%). The summary positive likelihood ratio of cough was 1.14 (95% CI 1.04 to 1.25) and that of fever 1.52 (95% CI 1.10 to 2.10). Sore throat had a summary positive likelihood ratio of 0.814 (95% CI 0.714 to 0.929), which means that its presence increases the probability of having an infectious disease other than COVID-19. Dyspnoea (12 studies) and fatigue (8 studies) had a sensitivity of 23.3% (95% CI 16.4% to 31.9%) and 40.2% (95% CI 19.4% to 65.1%) respectively. Their specificity was 75.7% (95% CI 65.2% to 83.9%) and 73.6% (95% CI 48.4% to 89.3%). The summary positive likelihood ratio of dyspnoea was 0.96 (95% CI 0.83 to 1.11) and that of fatigue 1.52 (95% CI 1.21 to 1.91), which means that the presence of fatigue slightly increases the probability of having COVID-19. Anosmia alone (7 studies), ageusia alone (5 studies), and anosmia or ageusia (6 studies) had summary sensitivities below 50% but summary specificities over 90%. Anosmia had a summary sensitivity of 26.4% (95% CI 13.8% to 44.6%) and a specificity of 94.2% (95% CI 90.6% to 96.5%). Ageusia had a summary sensitivity of 23.2% (95% CI 10.6% to 43.3%) and a specificity of 92.6% (95% CI 83.1% to 97.0%). Anosmia or ageusia had a summary sensitivity of 39.2% (95% CI 26.5% to 53.6%) and a specificity of 92.1% (95% CI 84.5% to 96.2%). The summary positive likelihood ratios of anosmia alone and anosmia or ageusia were 4.55 (95% CI 3.46 to 5.97) and 4.99 (95% CI 3.22 to 7.75) respectively, which is just below our arbitrary definition of a 'red flag', that is, a positive likelihood ratio of at least 5. The summary positive likelihood ratio of ageusia alone was 3.14 (95% CI 1.79 to 5.51). Twenty-four studies assessed combinations of different signs and symptoms, mostly combining olfactory symptoms. By combining symptoms with other information such as contact or travel history, age, gender, and a local recent case detection rate, some multivariable prediction scores reached a sensitivity as high as 90%.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AUTHORS' CONCLUSIONS: Most individual symptoms included in this review have poor diagnostic accuracy. Neither absence nor presence of symptoms are accurate enough to rule in or rule out the disease. The presence of anosmia or ageusia may be useful as a red flag for the presence of COVID-19. The presence of cough also supports further testing. There is currently no evidence to support further testing with PCR in any individuals presenting only with upper respiratory symptoms such as sore throat, coryza or rhinorrhoea. Combinations of symptoms with other readily available information such as contact or travel history, or the local recent case detection rate may prove more useful and should be further investigated in an unselected population presenting to primary care or hospital outpatient settings. The diagnostic accuracy of symptoms for COVID-19 is moderate to low and any testing strategy using symptoms as selection mechanism will result in both large numbers of missed cases and large numbers of people requiring testing. Which one of these is minimised, is determined by the goal of COVID-19 testing strategies, that is, controlling the epidemic by isolating every possible case versus identifying those with clinically important disease so that they can be monitored or treated to optimise their prognosis. The former will require a testing strategy that uses very few symptoms as entry criterion for testing, the latter could focus on more specific symptoms such as fever and anosmia.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35593186/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35593186</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC9121352/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC9121352</a> | DOI:<a href=https://doi.org/10.1002/14651858.CD013665.pub3>10.1002/14651858.CD013665.pub3</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35593186</guid>
      <pubDate>Fri, 20 May 2022 06:00:00 -0400</pubDate>
      <dc:creator>Thomas Struyf</dc:creator>
      <dc:creator>Jonathan J Deeks</dc:creator>
      <dc:creator>Jacqueline Dinnes</dc:creator>
      <dc:creator>Yemisi Takwoingi</dc:creator>
      <dc:creator>Clare Davenport</dc:creator>
      <dc:creator>Mariska Mg Leeflang</dc:creator>
      <dc:creator>René Spijker</dc:creator>
      <dc:creator>Lotty Hooft</dc:creator>
      <dc:creator>Devy Emperador</dc:creator>
      <dc:creator>Julie Domen</dc:creator>
      <dc:creator>Anouk Tans</dc:creator>
      <dc:creator>Stéphanie Janssens</dc:creator>
      <dc:creator>Dakshitha Wickramasinghe</dc:creator>
      <dc:creator>Viktor Lannoy</dc:creator>
      <dc:creator>Sebastiaan R A Horn</dc:creator>
      <dc:creator>Ann Van den Bruel</dc:creator>
      <dc:creator>Cochrane COVID-19 Diagnostic Test Accuracy Group</dc:creator>
      <dc:date>2022-05-20</dc:date>
      <dc:source>The Cochrane database of systematic reviews</dc:source>
      <dc:title>Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19</dc:title>
      <dc:identifier>pmid:35593186</dc:identifier>
      <dc:identifier>pmc:PMC9121352</dc:identifier>
      <dc:identifier>doi:10.1002/14651858.CD013665.pub3</dc:identifier>
    </item>
    <item>
      <title>Association between vitamin D deficiency and diabetic foot ulcer wound in diabetic subjects: A meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35567425/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>A meta-analysis was performed to evaluate the association between vitamin D deficiency and diabetic foot ulcer wounds in diabetic subjects. A systematic literature search up to March 2022 incorporated 7586 subjects with diabetes mellitus at the beginning of the study; 1565 were using diabetic subjects with foot ulcer wounds, and 6021 were non-ulcerated diabetic subjects. Statistical tools like the dichotomous and contentious method were used within a random or fixed-influence model to establish...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Int Wound J. 2022 May 14. doi: 10.1111/iwj.13836. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">A meta-analysis was performed to evaluate the association between vitamin D deficiency and diabetic foot ulcer wounds in diabetic subjects. A systematic literature search up to March 2022 incorporated 7586 subjects with diabetes mellitus at the beginning of the study; 1565 were using diabetic subjects with foot ulcer wounds, and 6021 were non-ulcerated diabetic subjects. Statistical tools like the dichotomous and contentious method were used within a random or fixed-influence model to establish the odds ratio (OR) and mean difference (MD) with 95% confidence intervals (CIs) to evaluate the influence of vitamin D deficiency in managing diabetic foot ulcer wound. Diabetic subjects with foot ulcer wounds had significantly lower vitamin D levels (MD, -6.48; 95% CI, -10.84 to -2.11, P &lt; .004), higher prevalence of vitamin D deficiency (&lt;50 nmoL/L) (OR, 1.82; 95% CI, 1.32-2.52, P &lt; .001), and higher prevalence of severe vitamin D deficiency (OR, 2.53; 95% CI, 1.65-3.89, P &lt; .001) compared with non-ulcerated diabetic subjects. Diabetic subjects with foot ulcer wounds had significantly lower vitamin D levels, higher prevalence of vitamin D deficiency, and higher prevalence of severe vitamin D deficiency compared with non-ulcerated diabetic subjects. Further studies are required to validate these findings.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35567425/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35567425</a> | DOI:<a href=https://doi.org/10.1111/iwj.13836>10.1111/iwj.13836</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35567425</guid>
      <pubDate>Sat, 14 May 2022 06:00:00 -0400</pubDate>
      <dc:creator>Juan Lin</dc:creator>
      <dc:creator>Xinxin Mo</dc:creator>
      <dc:creator>Yejun Yang</dc:creator>
      <dc:creator>Chao Tang</dc:creator>
      <dc:creator>Jia Chen</dc:creator>
      <dc:date>2022-05-14</dc:date>
      <dc:source>International wound journal</dc:source>
      <dc:title>Association between vitamin D deficiency and diabetic foot ulcer wound in diabetic subjects: A meta-analysis</dc:title>
      <dc:identifier>pmid:35567425</dc:identifier>
      <dc:identifier>doi:10.1111/iwj.13836</dc:identifier>
    </item>
    <item>
      <title>Severe bronchopulmonary dysplasia in extremely premature infants: a scoping review protocol for identifying risk factors</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35545385/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>INTRODUCTION: The remarkable improvement in the long-term prognosis of extremely premature infants has led to an increase in the number of cases of bronchopulmonary dysplasia (BPD). BPD affects pulmonary function and developmental outcomes, resulting in high chronic health burdens for infants and their families over the years. Therefore, identifying its risk factors in the early period of life and exploring better prophylactics and treatment strategies are important.The objectives of our scoping...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">BMJ Open. 2022 May 11;12(5):e062192. doi: 10.1136/bmjopen-2022-062192.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTRODUCTION: The remarkable improvement in the long-term prognosis of extremely premature infants has led to an increase in the number of cases of bronchopulmonary dysplasia (BPD). BPD affects pulmonary function and developmental outcomes, resulting in high chronic health burdens for infants and their families over the years. Therefore, identifying its risk factors in the early period of life and exploring better prophylactics and treatment strategies are important.The objectives of our scoping review are to screen available evidence, identify perinatal risk factors involved in the development and severity of BPD and devise a novel disease classification system that can predict long-term prognosis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND ANALYSIS: Eligibility criteria are as follows: articles published from 2002 to 2021; studies conducted in developed countries; articles written in English (PubMed) or Japanese (Ichushi); randomised controlled trials, prospective/retrospective cohort studies or case-control studies; extremely premature infants born before 28 weeks of gestational age; and articles in which endpoint was severe BPD as classified by the National Institute of Child Health and Human Development.We will screen the titles and abstracts of studies identified by independent reviewers using the population-concept-context framework. After a full-text review and data charting, we will provide the perinatal risk factors for severe BPD along with the risk ratio or odds ratio, 95% confidence interval and p values.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">ETHICS AND DISSEMINATION: Institutional review board approval is not required due to the nature of the study. The results of this review will be disseminated through peer-reviewed publications and presentations at relevant conferences.Protocol V.1, 22 September 2021 TRIAL REGISTRATION NUMBER: UMIN000045529.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35545385/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35545385</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC9096528/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC9096528</a> | DOI:<a href=https://doi.org/10.1136/bmjopen-2022-062192>10.1136/bmjopen-2022-062192</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35545385</guid>
      <pubDate>Wed, 11 May 2022 06:00:00 -0400</pubDate>
      <dc:creator>Shin Kato</dc:creator>
      <dc:creator>Masato Ito</dc:creator>
      <dc:creator>Makoto Saito</dc:creator>
      <dc:creator>Naoyuki Miyahara</dc:creator>
      <dc:creator>Fumihiko Namba</dc:creator>
      <dc:creator>Erika Ota</dc:creator>
      <dc:creator>Hidehiko Nakanishi</dc:creator>
      <dc:date>2022-05-11</dc:date>
      <dc:source>BMJ open</dc:source>
      <dc:title>Severe bronchopulmonary dysplasia in extremely premature infants: a scoping review protocol for identifying risk factors</dc:title>
      <dc:identifier>pmid:35545385</dc:identifier>
      <dc:identifier>pmc:PMC9096528</dc:identifier>
      <dc:identifier>doi:10.1136/bmjopen-2022-062192</dc:identifier>
    </item>
    <item>
      <title>Effect of educational interventions on level of epilepsy knowledge in children with epilepsy and parents: Systematic review and meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35534992/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSION: Educational interventions have high and beneficial effect on the level of epilepsy knowledge in the children with epilepsy and parents; can be used as effective interventions in the epilepsy management. However, due to low number of randomised controlled studies, further high-quality randomised controlled studies are needed about this topic.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Clin Nurs. 2022 May 9. doi: 10.1111/jocn.16346. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM AND OBJECTIVES: The aim of the study was to synthesise the effect of educational interventions on the level of epilepsy knowledge in children with epilepsy and parents.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Educational interventions are commonly used to provide knowledge about epilepsy management. One of the most important responsibilities of nurses is to inform children with epilepsy and parents in a skilful way.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN: Systematic review and meta-analysis based on PRISMA 2020.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We searched CINAHL, Cochrane Library, Science Direct, Web of Science, Ovid, PubMed, Scopus, Springer Link, ProQuest, TR Index ending March 2021. The review followed the PRISMA guidelines. This meta-analysis was analysed in Comprehensive Meta-Analysis version 3 software. The risk of bias of included studies was assessed with the Cochrane handbook. The results were the level of epilepsy knowledge of children and parents.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Ten studies meeting the inclusion criteria were included in this meta-analysis, including four randomised studies and six non-randomised studies. Educational interventions had large effect on improving the level of epilepsy knowledge in children with epilepsy (p &lt; .001, Hedge's g = 1.19) and parents (p &lt; .001, Hedge's g = 1.41). As a result of the subgroup analyses, significant differences were found only in the type of educational intervention. It was found that traditional education is more effective than technology-based education in improving the level of epilepsy knowledge in parents (p = .005, Hedge's g = 1.77).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Educational interventions have high and beneficial effect on the level of epilepsy knowledge in the children with epilepsy and parents; can be used as effective interventions in the epilepsy management. However, due to low number of randomised controlled studies, further high-quality randomised controlled studies are needed about this topic.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RELEVANCE TO CLINICAL PRACTICE: The findings will contribute to the use of educational interventions in the epilepsy management for health professionals, especially nurses. Thus these interventions will contribute to improving epilepsy management of children with epilepsy and parents.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35534992/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35534992</a> | DOI:<a href=https://doi.org/10.1111/jocn.16346>10.1111/jocn.16346</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35534992</guid>
      <pubDate>Tue, 10 May 2022 06:00:00 -0400</pubDate>
      <dc:creator>Fatma D Turan</dc:creator>
      <dc:creator>Şefika T Yangöz</dc:creator>
      <dc:date>2022-05-10</dc:date>
      <dc:source>Journal of clinical nursing</dc:source>
      <dc:title>Effect of educational interventions on level of epilepsy knowledge in children with epilepsy and parents: Systematic review and meta-analysis</dc:title>
      <dc:identifier>pmid:35534992</dc:identifier>
      <dc:identifier>doi:10.1111/jocn.16346</dc:identifier>
    </item>
    <item>
      <title>The Effect of Parental Presence on Pain Levels of Children During Invasive Procedures: A Systematic Review</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35523626/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: Parental presence and parental involvement during invasive procedures effectively reduced the children's pain levels. Since the number of studies with a high level of evidence regarding the effect of family participation on pain level is limited, it is recommended to conduct more randomized controlled studies.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Pain Manag Nurs. 2022 May 3:S1524-9042(22)00101-1. doi: 10.1016/j.pmn.2022.03.011. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM: This systematic review was conducted to determine the effect of parental presence on the child's pain intensity during invasive procedures.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN: A systematic review.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHOD: The systematic review was conducted in July 2019 and updated in December 2020 to include the latest research published during the publication process by scanning the articles in English. Scopus, Pubmed, Cochrane, Science Direct, MedLine databases were used for scanning. The keywords "parental presence", "family presence", "parent involvement", "invasive procedures", "venipuncture", "painful procedures", "child", "children", "pediatric" were used in the scanning. Preferred Reporting Items for Systematic reviews and Meta-Analyses protocol was followed to prepare the study and the report, and the systematic review was created according to the patient, intervention, comparison, outcomes (PICOS) strategy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 248 articles were reached, and the full texts of 18 articles were evaluated for eligibility. After the articles excluded by the full-text search were eliminated, six studies, involving 730 children with a sample aged between 0-12 years, were included in the analysis. In 4 studies, it was determined that having a parent with the child during the invasive procedure significantly decreased the pain level, and in 2 studies, there was no statistically significant decrease in the pain level of the children.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Parental presence and parental involvement during invasive procedures effectively reduced the children's pain levels. Since the number of studies with a high level of evidence regarding the effect of family participation on pain level is limited, it is recommended to conduct more randomized controlled studies.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35523626/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35523626</a> | DOI:<a href=https://doi.org/10.1016/j.pmn.2022.03.011>10.1016/j.pmn.2022.03.011</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35523626</guid>
      <pubDate>Fri, 06 May 2022 06:00:00 -0400</pubDate>
      <dc:creator>Merve Azak</dc:creator>
      <dc:creator>Gözde Aksucu</dc:creator>
      <dc:creator>Seda Çağlar</dc:creator>
      <dc:date>2022-05-06</dc:date>
      <dc:source>Pain management nursing : official journal of the American Society of Pain Management Nurses</dc:source>
      <dc:title>The Effect of Parental Presence on Pain Levels of Children During Invasive Procedures: A Systematic Review</dc:title>
      <dc:identifier>pmid:35523626</dc:identifier>
      <dc:identifier>doi:10.1016/j.pmn.2022.03.011</dc:identifier>
    </item>
    <item>
      <title>A WeChat-Based Rehabilitation Platform for Children and Adolescents with Congenital Heart Disease to Promote Cardiac FITness (HeartFIT): Protocol for a Mixed-Methods Strategy from Evidence-Based Design to Pilot Study</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35519154/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>Progress in medical and surgical care has tremendously improved the survival rates of children with congenital heart disease (CHD). However, reduced aerobic capacity and health-related issues remain a threaten to quality survival and prevention of related complications among children and adolescents with CHD. This research program aims to develop and evaluate a WeChat-based health platform (HeartFIT) to facilitate cardiac rehabilitation and promote physical fitness for this rapidly expanding...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Multidiscip Healthc. 2022 Apr 29;15:907-920. doi: 10.2147/JMDH.S349519. eCollection 2022.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Progress in medical and surgical care has tremendously improved the survival rates of children with congenital heart disease (CHD). However, reduced aerobic capacity and health-related issues remain a threaten to quality survival and prevention of related complications among children and adolescents with CHD. This research program aims to develop and evaluate a WeChat-based health platform (HeartFIT) to facilitate cardiac rehabilitation and promote physical fitness for this rapidly expanding young population. The study protocol describes the use of an iterative process of using a mixed-methods strategy to develop, refine, and pilot test the proposed HeartFIT platform. A sequential problem-solving process comprising four iterative phases with ongoing end-user input will be implemented. In phase 1, relevant literature was systematically reviewed (completed) and then child-parent dyads will be interviewed to understand the broad context and the requirements and considerations of the target population toward the WeChat-based rehabilitation platform. In phase 2, key features and priority functionalities for the platform will be ideated and refined, and a digital interactive prototype will be created. In phase 3, heuristic evaluation and three rounds of end-user testing will be conducted to ensure further refinement and usability of the prototype. In phase 4, a prospective pilot study will be performed to investigate the feasibility, acceptability, and preliminary efficacy of the developed platform over a 12-week intervention period. If HeartFIT intervention is feasible, acceptable, and demonstrates promising efficacy, an adequately powered randomized controlled trial (future work) will be deployed to test the real-world effectiveness of the intervention.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35519154/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35519154</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC9064066/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC9064066</a> | DOI:<a href=https://doi.org/10.2147/JMDH.S349519>10.2147/JMDH.S349519</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35519154</guid>
      <pubDate>Fri, 06 May 2022 06:00:00 -0400</pubDate>
      <dc:creator>Yuan Li</dc:creator>
      <dc:creator>Yaxin Zhou</dc:creator>
      <dc:creator>Miao Chen</dc:creator>
      <dc:creator>Mei R Fu</dc:creator>
      <dc:creator>Biru Luo</dc:creator>
      <dc:creator>Pengming Yu</dc:creator>
      <dc:creator>Hong Zheng</dc:creator>
      <dc:creator>Fangfei Liu</dc:creator>
      <dc:date>2022-05-06</dc:date>
      <dc:source>Journal of multidisciplinary healthcare</dc:source>
      <dc:title>A WeChat-Based Rehabilitation Platform for Children and Adolescents with Congenital Heart Disease to Promote Cardiac FITness (HeartFIT): Protocol for a Mixed-Methods Strategy from Evidence-Based Design to Pilot Study</dc:title>
      <dc:identifier>pmid:35519154</dc:identifier>
      <dc:identifier>pmc:PMC9064066</dc:identifier>
      <dc:identifier>doi:10.2147/JMDH.S349519</dc:identifier>
    </item>
    <item>
      <title>Mother-to-child transmission of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among pregnant women with single, dual or triplex infections of human immunodeficiency virus, hepatitis B virus and hepatitis C virus in Nigeria: A systematic review and meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35509955/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>Objectives: To systematically review literature and identify mother-to-child transmission rates of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among pregnant women with single, dual, or triplex infections of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in Nigeria. PRISMA guidelines were employed. Searches were on 19 February 2021 in PubMed, Google Scholar and CINAHL on studies published from 1 February 2001 to 31 January 2021 using keywords:...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">SAGE Open Med. 2022 Apr 28;10:20503121221095411. doi: 10.1177/20503121221095411. eCollection 2022.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"><b>Objectives:</b> To systematically review literature and identify mother-to-child transmission rates of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among pregnant women with single, dual, or triplex infections of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in Nigeria. PRISMA guidelines were employed. Searches were on 19 February 2021 in PubMed, Google Scholar and CINAHL on studies published from 1 February 2001 to 31 January 2021 using keywords: "MTCT," "dual infection," "triplex infection," "HIV," "HBV," and "HCV." Studies that reported mother-to-child transmission rate of at least any of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among pregnant women and their infant pairs with single, dual, or triplex infections of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in Nigeria irrespective of publication status or language were eligible. Data were extracted independently by two authors with disagreements resolved by a third author. Meta-analysis was performed using the random effects model of DerSimonian and Laird, to produce summary mother-to-child transmission rates in terms of percentage with 95% confidence interval. Protocol was prospectively registered in PROSPERO: CRD42020202070. The search identified 849 reports. After screening titles and abstracts, 25 full-text articles were assessed for eligibility and 18 were included for meta-analysis. We identified one ongoing study. Pooled mother-to-child transmission rates were 2.74% (95% confidence interval: 2.48%-2.99%; 5863 participants; 15 studies) and 55.49% (95% confidence interval: 35.93%-75.04%; 433 participants; three studies), among mother-infant pairs with mono-infection of human immunodeficiency virus and hepatitis B virus, respectively, according to meta-analysis. Overall, the studies showed a moderate risk of bias. The pooled rate of mother-to-child transmission of human immunodeficiency virus was 2.74% and hepatitis B virus was 55.49% among mother-infant pairs with mono-infection of HIV and hepatitis B virus, respectively. No data exists on rates of mother-to-child transmission of hepatitis C virus on mono-infection or mother-to-child transmission of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among mother-infant pairs with dual or triplex infection of HIV, hepatitis B virus and HCV in Nigeria.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35509955/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35509955</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC9058348/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC9058348</a> | DOI:<a href=https://doi.org/10.1177/20503121221095411>10.1177/20503121221095411</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35509955</guid>
      <pubDate>Thu, 05 May 2022 06:00:00 -0400</pubDate>
      <dc:creator>George Uchenna Eleje</dc:creator>
      <dc:creator>Chinyere Ukamaka Onubogu</dc:creator>
      <dc:creator>Preye Owen Fiebai</dc:creator>
      <dc:creator>Ikechukwu Innocent Mbachu</dc:creator>
      <dc:creator>Godwin Otuodichinma Akaba</dc:creator>
      <dc:creator>Olabisi Morebise Loto</dc:creator>
      <dc:creator>Hadiza Abdullahi Usman</dc:creator>
      <dc:creator>Ayyuba Rabiu</dc:creator>
      <dc:creator>Moriam Taiwo Chibuzor</dc:creator>
      <dc:creator>Rebecca Chinyelu Chukwuanukwu</dc:creator>
      <dc:creator>Ngozi Nneka Joe-Ikechebelu</dc:creator>
      <dc:creator>Chike Henry Nwankwo</dc:creator>
      <dc:creator>Stephen Okoroafor Kalu</dc:creator>
      <dc:creator>Chukwuanugo Nkemakonam Ogbuagu</dc:creator>
      <dc:creator>Shirley Nneka Chukwurah</dc:creator>
      <dc:creator>Chinwe Elizabeth Uzochukwu</dc:creator>
      <dc:creator>Ijeoma Chioma Oppah</dc:creator>
      <dc:creator>Aishat Ahmed</dc:creator>
      <dc:creator>Richard Obinwanne Egeonu</dc:creator>
      <dc:creator>Chiamaka Henrietta Jibuaku</dc:creator>
      <dc:creator>Samuel Oluwagbenga Inuyomi</dc:creator>
      <dc:creator>Bukola Abimbola Adesoji</dc:creator>
      <dc:creator>Ubong Inyang Anyang</dc:creator>
      <dc:creator>Uchenna Chukwunonso Ogwaluonye</dc:creator>
      <dc:creator>Ekene Agatha Emeka</dc:creator>
      <dc:creator>Odion Emmanuel Igue</dc:creator>
      <dc:creator>Ogbonna Dennis Okoro</dc:creator>
      <dc:creator>Prince Ogbonnia Aja</dc:creator>
      <dc:creator>Chiamaka Perpetua Chidozie</dc:creator>
      <dc:creator>Hadiza Sani Ibrahim</dc:creator>
      <dc:creator>Fatima Ele Aliyu</dc:creator>
      <dc:creator>Aisha Ismaila Numan</dc:creator>
      <dc:creator>Solace Amechi Omoruyi</dc:creator>
      <dc:creator>Osita Samuel Umeononihu</dc:creator>
      <dc:creator>Chukwuemeka Chukwubuikem Okoro</dc:creator>
      <dc:creator>Ifeanyi Kingsley Nwaeju</dc:creator>
      <dc:creator>Arinze Anthony Onwuegbuna</dc:creator>
      <dc:creator>Eric Okechukwu Umeh</dc:creator>
      <dc:creator>Sussan Ifeyinwa Nweje</dc:creator>
      <dc:creator>Lydia Ijeoma Eleje</dc:creator>
      <dc:creator>Ifeoma Clara Ajuba</dc:creator>
      <dc:creator>David Chibuike Ikwuka</dc:creator>
      <dc:creator>Emeka Philip Igbodike</dc:creator>
      <dc:creator>Chisom God'swill Chigbo</dc:creator>
      <dc:creator>Uzoamaka Rufina Ebubedike</dc:creator>
      <dc:creator>Chigozie Geoffrey Okafor</dc:creator>
      <dc:creator>Nnaedozie Paul Obiegbu</dc:creator>
      <dc:creator>Ibrahim Adamu Yakasai</dc:creator>
      <dc:creator>Oliver Chukwujekwu Ezechi</dc:creator>
      <dc:creator>Joseph Ifeanyichukwu Ikechebelu</dc:creator>
      <dc:creator>Triplex Infection in Pregnancy Collaboration Group1–36</dc:creator>
      <dc:date>2022-05-05</dc:date>
      <dc:source>SAGE open medicine</dc:source>
      <dc:title>Mother-to-child transmission of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among pregnant women with single, dual or triplex infections of human immunodeficiency virus, hepatitis B virus and hepatitis C virus in Nigeria: A systematic review and meta-analysis</dc:title>
      <dc:identifier>pmid:35509955</dc:identifier>
      <dc:identifier>pmc:PMC9058348</dc:identifier>
      <dc:identifier>doi:10.1177/20503121221095411</dc:identifier>
    </item>
    <item>
      <title>Quality of patient-reported outcome reporting in trials of diabetes in pregnancy: a systematic review</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35483543/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: Researchers should be mindful of the importance of PRO inclusion and reporting and include reliable PROs in trials.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Diabetes Res Clin Pract. 2022 Apr 25:109879. doi: 10.1016/j.diabres.2022.109879. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Patient-reported outcomes (PROs) are reports of the patient's health status that come directly from the patient without interpretation by the clinician or anyone else. They are increasingly used in randomised controlled trials (RCTs). In this systematic review we identified RCTs conducted in women with diabetes in pregnancy which included PROs in their primary or secondary outcomes. We then evaluated the quality of PRO reporting against an internationally accepted reporting framework (Consolidated Standards of Reporting Trials (CONSORT-PRO) guidelines).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We searched online databases for studies published 2013-2021 using a combination of keywords. Two authors reviewed all abstracts independently. Data on study characteristics and the quality of PRO reporting were extracted from relevant studies. We conducted a multiple regression analysis to identify factors associated with high quality reporting.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We identified 7122 citations. Thirty-five articles were included for review. Only 17% of RCTs included a PRO as a primary or secondary outcome. Out of a maximum score of 100 the median score was 46, indicating sub-optimal reporting. A multiple regression analysis did not reveal any factors associated with high quality reporting.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Researchers should be mindful of the importance of PRO inclusion and reporting and include reliable PROs in trials.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35483543/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35483543</a> | DOI:<a href=https://doi.org/10.1016/j.diabres.2022.109879>10.1016/j.diabres.2022.109879</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35483543</guid>
      <pubDate>Thu, 28 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>C Newman</dc:creator>
      <dc:creator>O Kgosidialwa</dc:creator>
      <dc:creator>L Dervan</dc:creator>
      <dc:creator>D Bogdanet</dc:creator>
      <dc:creator>A M Egan</dc:creator>
      <dc:creator>L Biesty</dc:creator>
      <dc:creator>D Devane</dc:creator>
      <dc:creator>P M O'Shea</dc:creator>
      <dc:creator>F P Dunne</dc:creator>
      <dc:date>2022-04-28</dc:date>
      <dc:source>Diabetes research and clinical practice</dc:source>
      <dc:title>Quality of patient-reported outcome reporting in trials of diabetes in pregnancy: a systematic review</dc:title>
      <dc:identifier>pmid:35483543</dc:identifier>
      <dc:identifier>doi:10.1016/j.diabres.2022.109879</dc:identifier>
    </item>
    <item>
      <title>A systematic review of the effect of lavender on cancer complications</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35462027/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: This review provides scientific evidence regarding the effectiveness of lavender in mitigating cancer complications. Healthcare providers are suggested to use lavender in patient care along with other healthcare interventions to relieve cancer complications.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Complement Ther Med. 2022 Aug;67:102836. doi: 10.1016/j.ctim.2022.102836. Epub 2022 Apr 21.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: Despite advances in the diagnosis and treatment of cancer, patients still suffer from the various physical and psychological complications of cancer. The aim of this research was to integrate and synthesize relevant scientific evidence about the effect of lavender on cancer complications.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A systematic review of the international literature was undertaken. The search process encompassed four databases of PubMed [including MEDLINE], Web of Science, Scopus, and Cochrane library without time and language limits. All types of interventional studies examining the effects of lavender on cancer complications were included in data analysis and research synthesis. Relevant data were obtained from eligible studies after quality appraisal using appropriate methodological tools. Given that meta-analysis could not performed, the review findings were synthesized narratively.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Thirteen studies were included in this review with a total of 838 patients. Nine studies used a randomized controlled trial design and the majority of them were conducted on patients with multiple types of cancer. Lavender was often used as inhalation aromatherapy. In the majority of the included studies, lavender was significantly effective in the reduction of anxiety and pain, and improved sleep quality and vital signs.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This review provides scientific evidence regarding the effectiveness of lavender in mitigating cancer complications. Healthcare providers are suggested to use lavender in patient care along with other healthcare interventions to relieve cancer complications.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35462027/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35462027</a> | DOI:<a href=https://doi.org/10.1016/j.ctim.2022.102836>10.1016/j.ctim.2022.102836</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35462027</guid>
      <pubDate>Sun, 24 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Abbas Mardani</dc:creator>
      <dc:creator>Maryam Maleki</dc:creator>
      <dc:creator>Nasrin Hanifi</dc:creator>
      <dc:creator>Yasaman Borghei</dc:creator>
      <dc:creator>Mojtaba Vaismoradi</dc:creator>
      <dc:date>2022-04-24</dc:date>
      <dc:source>Complementary therapies in medicine</dc:source>
      <dc:title>A systematic review of the effect of lavender on cancer complications</dc:title>
      <dc:identifier>pmid:35462027</dc:identifier>
      <dc:identifier>doi:10.1016/j.ctim.2022.102836</dc:identifier>
    </item>
    <item>
      <title>Does Adherence to the Mediterranean Diet Have a Protective Effect against Asthma and Allergies in Children? A Systematic Review</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35458180/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>Dietary pattern may potentially impact on the pathogenesis of asthma and allergies. The Mediterranean Diet (MD) has significant health benefits due to its antioxidant and anti-inflammatory properties. The aim of this systematic review was to investigate the effectiveness of adherence to the MD against asthma and allergies in childhood. Hence, a systematic literature search was conducted on PubMed, ESBCO (Cinahl), Scopus, and the Cochrane Library databases up to 26 January 2022. The total number...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Nutrients. 2022 Apr 13;14(8):1618. doi: 10.3390/nu14081618.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Dietary pattern may potentially impact on the pathogenesis of asthma and allergies. The Mediterranean Diet (MD) has significant health benefits due to its antioxidant and anti-inflammatory properties. The aim of this systematic review was to investigate the effectiveness of adherence to the MD against asthma and allergies in childhood. Hence, a systematic literature search was conducted on PubMed, ESBCO (Cinahl), Scopus, and the Cochrane Library databases up to 26 January 2022. The total number of articles obtained, after the initial search on the databases was conducted, was 301. Twelve studies were included, after the removal of duplicates and screening for eligibility. Our findings indicated a protective role of the MD against childhood asthma, but they also imply that the MD probably does not affect the development of allergies. Nevertheless, the heterogeneity and limitations of the studies highlight the need for randomized controlled trials that will focus on the pediatric population and hopefully provide more robust evidence.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35458180/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35458180</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC9031000/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC9031000</a> | DOI:<a href=https://doi.org/10.3390/nu14081618>10.3390/nu14081618</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35458180</guid>
      <pubDate>Sat, 23 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Despoina Koumpagioti</dc:creator>
      <dc:creator>Barbara Boutopoulou</dc:creator>
      <dc:creator>Dafni Moriki</dc:creator>
      <dc:creator>Kostas N Priftis</dc:creator>
      <dc:creator>Konstantinos Douros</dc:creator>
      <dc:date>2022-04-23</dc:date>
      <dc:source>Nutrients</dc:source>
      <dc:title>Does Adherence to the Mediterranean Diet Have a Protective Effect against Asthma and Allergies in Children? A Systematic Review</dc:title>
      <dc:identifier>pmid:35458180</dc:identifier>
      <dc:identifier>pmc:PMC9031000</dc:identifier>
      <dc:identifier>doi:10.3390/nu14081618</dc:identifier>
    </item>
    <item>
      <title>Prevention of Non-Contact Anterior Cruciate Ligament Injuries among Youth Female Athletes: An Umbrella Review</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35457516/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>Anterior cruciate ligament (ACL) injuries account for a large percentage of knee injuries, disproportionately affecting female athletes. To help health professionals stay current, we performed an umbrella review to evaluate the effectiveness of ACL injury prevention programs in reducing non-contact ACL injury rates, determine the effective components within interventions, and provide clinical recommendations. Twelve databases (Medline, Embase, Cochrane Database of Systematic Reviews,...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Int J Environ Res Public Health. 2022 Apr 12;19(8):4648. doi: 10.3390/ijerph19084648.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Anterior cruciate ligament (ACL) injuries account for a large percentage of knee injuries, disproportionately affecting female athletes. To help health professionals stay current, we performed an umbrella review to evaluate the effectiveness of ACL injury prevention programs in reducing non-contact ACL injury rates, determine the effective components within interventions, and provide clinical recommendations. Twelve databases (Medline, Embase, Cochrane Database of Systematic Reviews, SPORTDiscus, Cumulative Index to Nursing and Allied Health Literature, PEDro, Web of Science Core Collection, Epistemonikos, TRIP, BC Guidelines and Protocols, CPG Infobase, ProQuest Dissertations and Theses Global) were searched in May 2021 to identify relevant systematic reviews and meta-analyses. Four databases were searched again in September 2021 to identify recent primary literature. Non-contact ACL injury data were extracted to calculate incidence rate ratios (IRRs) and these were combined using an inverse variance random-effects model. A qualitative assessment of included reviews was performed. The methodological quality of the studies was assessed using a Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2) or Cochrane Risk-of-Bias Tool for Randomized Trials (RoB 2). Sixteen reviews and two primary studies met the inclusion criteria. Across 11 primary studies, prevention programs were effective in reducing non-contact ACL injuries by 64% (IRR = 0.36 (95% CI: 0.18-0.70)). A multi-faceted exercise program, beginning in the pre-season and containing at least three exercise types, may be beneficial in reducing ACL injury risk.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35457516/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35457516</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC9027388/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC9027388</a> | DOI:<a href=https://doi.org/10.3390/ijerph19084648>10.3390/ijerph19084648</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35457516</guid>
      <pubDate>Sat, 23 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Anmol T Mattu</dc:creator>
      <dc:creator>Brianna Ghali</dc:creator>
      <dc:creator>Vanessa Linton</dc:creator>
      <dc:creator>Alex Zheng</dc:creator>
      <dc:creator>Ian Pike</dc:creator>
      <dc:date>2022-04-23</dc:date>
      <dc:source>International journal of environmental research and public health</dc:source>
      <dc:title>Prevention of Non-Contact Anterior Cruciate Ligament Injuries among Youth Female Athletes: An Umbrella Review</dc:title>
      <dc:identifier>pmid:35457516</dc:identifier>
      <dc:identifier>pmc:PMC9027388</dc:identifier>
      <dc:identifier>doi:10.3390/ijerph19084648</dc:identifier>
    </item>
    <item>
      <title>Prevalence of sleep disorders in children with chronic kidney disease: a meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35445975/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: Sleep disorders are common in children with CKD. Our results indicate that while the prevalence rates of various sleep disorders were higher in children on dialysis than in children not on dialysis, the prevalence of excessive daytime sleepiness was statistically significant in children on dialysis. A higher resolution version of the Graphical abstract is available as Supplementary information.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Pediatr Nephrol. 2022 Apr 20. doi: 10.1007/s00467-022-05536-y. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The reported prevalence of sleep disorders in children with chronic kidney disease (CKD) varies greatly. A quantitative meta-analysis to estimate the prevalence of sleep disorders among pediatric CKD patients may provide further information.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The objective of this study is to estimate the prevalence of sleep disorders in children with CKD. The study protocol was registered on PROSPERO (registration number CRD42021268378).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DATA SOURCES: Two authors independently searched the PubMed, MEDLINE, EMBASE, and Cochrane review databases up to June 2021.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STUDY ELIGIBILITY CRITERIA: Eligible studies include data of prevalence of sleep disorders in children with CKD.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STUDY APPRAISAL AND SYNTHESIS METHODS: The prevalence of restless legs syndrome, sleep-disordered breathing, pediatric obstructive sleep apnea (i.e., apnea-hypopnea index &gt; 1 event/h in polysomnography), excessive daytime sleepiness, and insomnia/insufficient sleep was estimated using a random-effects model. Subgroup analyses were conducted to compare the prevalence of sleep disorders between children on dialysis and not on dialysis. This meta-analysis included 12 studies with 595 children (mean age: 12.9 years; gender ratio: 55.6% boys; mean sample size: 49.6 patients).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The prevalence of restless legs syndrome in children with CKD was 21% (95% confidence interval [CI], 14-30%). The prevalence of sleep-disordered breathing, pediatric obstructive sleep apnea, excessive daytime sleepiness, and insomnia/insufficient sleep was 22% (95% CI, 12-36%), 34% (95% CI, 19-53%), 27% (95% CI, 17-41%), and 14% (95% CI, 7-27%), respectively. Subgroup analysis revealed the pooled prevalence of excessive daytime sleepiness was significantly higher in children on dialysis than in children not on dialysis (43.3% vs. 11.2%; P = 0.018). Children on dialysis also had a high prevalence of other sleeping disorders, although the differences did not reach statistical significance. Children with CKD exhibited a 3.9-fold (95% CI, 1.37 to 10.93) increased risk of restless legs syndrome and a 9.6-fold (95% CI, 3.57 to 25.76) increased risk of excessive daytime sleepiness compared with controls.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">LIMITATIONS: The selected papers are of small sample size, lack of a control group, and exhibit substantial heterogeneity.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Sleep disorders are common in children with CKD. Our results indicate that while the prevalence rates of various sleep disorders were higher in children on dialysis than in children not on dialysis, the prevalence of excessive daytime sleepiness was statistically significant in children on dialysis. A higher resolution version of the Graphical abstract is available as Supplementary information.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35445975/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35445975</a> | DOI:<a href=https://doi.org/10.1007/s00467-022-05536-y>10.1007/s00467-022-05536-y</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35445975</guid>
      <pubDate>Thu, 21 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Kun-Tai Kang</dc:creator>
      <dc:creator>Ming-Tzer Lin</dc:creator>
      <dc:creator>Yin-Cheng Chen</dc:creator>
      <dc:creator>Chia-Hsuan Lee</dc:creator>
      <dc:creator>Wei-Chung Hsu</dc:creator>
      <dc:creator>Ray-E Chang</dc:creator>
      <dc:date>2022-04-21</dc:date>
      <dc:source>Pediatric nephrology (Berlin, Germany)</dc:source>
      <dc:title>Prevalence of sleep disorders in children with chronic kidney disease: a meta-analysis</dc:title>
      <dc:identifier>pmid:35445975</dc:identifier>
      <dc:identifier>doi:10.1007/s00467-022-05536-y</dc:identifier>
    </item>
    <item>
      <title>Comparison of ultrasound-guided peripheral intravenous catheter insertion with landmark technique in paediatric patients: A systematic review and meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35441751/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: Large clinical trials are needed to explore the effectiveness of ultrasound guidance for PIVC insertion in paediatrics. Specifically, children with difficult intravenous access might benefit most from this technology.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Paediatr Child Health. 2022 Apr 20. doi: 10.1111/jpc.15985. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Paediatric peripheral intravenous catheter (PIVC) insertion using traditional landmark insertion technique can be difficult.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM: To systematically review the evidence comparing landmark to ultrasound guidance for PIVC insertion in general paediatric patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STUDY DESIGN: Cochrane methodology to systematically search for randomised controlled trials comparing landmark to ultrasound-guided PIVC insertion.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DATA SOURCES: Cochrane Central Register of Controlled Trials, US National Library of Medicine, Cumulative Index to Nursing and Allied Health, Embase.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DATA EXTRACTION: English-language, paediatric trials published after 2000, reporting first-attempt insertion success, overall PIVC insertion success, and/or time to insert were included. Central venous, non-venous and trials including only difficult intravenous access were excluded. Data were independently extracted and critiqued for quality using GRADE by three authors, and analysed using random effects, with results expressed as risk ratios (RR), mean differences (MD) and 95% confidence intervals (CI). Registration (CRD42020175314).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of 70 titles identified, 5 studies (995 patients; 949 PIVCs) were included. There was no evidence of an effect of ultrasound guidance, compared to landmark, for first-attempt insertion success (RR 1.27; 95% CI 0.90-1.78; I<sup>2</sup> = 88%; moderate quality evidence), overall insertion success (RR 1.14; 95% CI 0.90-1.44; I<sup>2</sup> = 82%; low quality evidence), or time to insertion (mean difference -3.03 min; 95% CI -12.73 to 6.67; I<sup>2</sup> = 92%; low quality evidence).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">LIMITATIONS: Small sample sizes, inconsistent outcomes and definitions in primary studies precluded definitive conclusions.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Large clinical trials are needed to explore the effectiveness of ultrasound guidance for PIVC insertion in paediatrics. Specifically, children with difficult intravenous access might benefit most from this technology.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35441751/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35441751</a> | DOI:<a href=https://doi.org/10.1111/jpc.15985>10.1111/jpc.15985</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35441751</guid>
      <pubDate>Wed, 20 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Tricia M Kleidon</dc:creator>
      <dc:creator>Jessica Schults</dc:creator>
      <dc:creator>Rebecca Paterson</dc:creator>
      <dc:creator>Claire M Rickard</dc:creator>
      <dc:creator>Amanda J Ullman</dc:creator>
      <dc:date>2022-04-20</dc:date>
      <dc:source>Journal of paediatrics and child health</dc:source>
      <dc:title>Comparison of ultrasound-guided peripheral intravenous catheter insertion with landmark technique in paediatric patients: A systematic review and meta-analysis</dc:title>
      <dc:identifier>pmid:35441751</dc:identifier>
      <dc:identifier>doi:10.1111/jpc.15985</dc:identifier>
    </item>
    <item>
      <title>A multi-institutional study of post-traumatic stress disorder and its risk factors in Ethiopian pediatric patients with physical trauma</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35428231/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSION AND RECOMMENDATION: The prevalence of PTSD was found to be high among pediatric patients who had experienced physical trauma. Special attention should be given to female patients, aged 8 to 10 years old, who have a chronic illness, for those who complain of severe pain and engaging others to provide good social support systems, are strongly recommended to alleviate PTSD in this segment of population.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">BMC Psychiatry. 2022 Apr 15;22(1):271. doi: 10.1186/s12888-022-03930-2.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTRODUCTION: Post Traumatic Stress Disorder (PTSD) was more common in children who had suffered physical trauma than in adults. Despite its prevalence, the prevalence and factors associated with PTSD in pediatric patients with physical trauma are unknown in Ethiopia. As a result, the purpose of this study was to determine the prevalence of PTSD and associated factors among pediatric patients with physical trauma who attended Northwest Amhara referral hospitals.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: An institutional-based cross-sectional study design was used in 422 pediatric patients with physical trauma aged 8-18 years from March 15 to May 15/2021. Using a systematic random sampling technique, data were collected from a sample of selected trauma patients via interviews and chart review. A standardized, pre-tested Child PTSD Symptom Scale was used to assess the severity of PTSD. Epidata 4.6 was used to enter the data, and Stata 14.0 was used to analyze it. Bivariable and multivariable binary logistic regression models were used to identify PTSD determinants.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULT: The study included 422 paediatric patients who had suffered physical trauma, with a response rate of 97.87 percent. PTSD was found in 22.03 percent of paediatric patients with physical trauma in Northwest Amhara referral hospitals. The study discovered that female gender (AOR = 3.04, 95 percent CI: 1.58-5.84), age of 8 to 10 years old (AOR = 3.70, 95 percent CI: 1.39-9.87), having a chronic medical illness (AOR = 5.99, 95 percent CI: 2.60-13.77), having severe pain (AOR = 3.17, 95 percent CI: 1.12-8.99), low social support (AOR = 8.97, 95 percent CI: 4.04-19 were associated with PTSD.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION AND RECOMMENDATION: The prevalence of PTSD was found to be high among pediatric patients who had experienced physical trauma. Special attention should be given to female patients, aged 8 to 10 years old, who have a chronic illness, for those who complain of severe pain and engaging others to provide good social support systems, are strongly recommended to alleviate PTSD in this segment of population.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35428231/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35428231</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC9011951/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC9011951</a> | DOI:<a href=https://doi.org/10.1186/s12888-022-03930-2>10.1186/s12888-022-03930-2</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35428231</guid>
      <pubDate>Sat, 16 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Tadesse Tarik Tamir</dc:creator>
      <dc:creator>Selam Fisiha Kassa</dc:creator>
      <dc:creator>Daniel Ayelegne Gebeyehu</dc:creator>
      <dc:date>2022-04-16</dc:date>
      <dc:source>BMC psychiatry</dc:source>
      <dc:title>A multi-institutional study of post-traumatic stress disorder and its risk factors in Ethiopian pediatric patients with physical trauma</dc:title>
      <dc:identifier>pmid:35428231</dc:identifier>
      <dc:identifier>pmc:PMC9011951</dc:identifier>
      <dc:identifier>doi:10.1186/s12888-022-03930-2</dc:identifier>
    </item>
    <item>
      <title>Prevalence and associated factors of treatment failure among children on ART in Ethiopia: A systematic review and meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35421084/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: This study revealed that treatment failure among children on ART was high in Ethiopia. Poor ART adherence, advanced WHO clinical staging, opportunistic infections, and low level of CD4 cell counts increased the risk of treatment failure.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">PLoS One. 2022 Apr 14;17(4):e0261611. doi: 10.1371/journal.pone.0261611. eCollection 2022.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: As the use of antiretroviral therapy (ART) increases, the issue of treatment failure is still a global challenge, particularly in a resource limited settings including Ethiopia. The results of former studies in Ethiopia were highly variable and inconsistent across studies. Thus, this systematic review and meta-analysis intended to provide the pooled estimation of treatment failure and associated factors among children on antiretroviral therapy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We searched international databases (i.e., PubMed, Google Scholar, Web of Science, Ethiopian Universities' online repository library, Scopus, and the Cochrane Library) during the period of February 30 to April 7, 2021. All identified observational studies reporting the proportion of treatment failure among HIV positive children in Ethiopia were included. Heterogeneity of the studies was checked using I2 test and Cochrane Q test statistics. We run Begg's regression test to assess publication bias. A random-effects meta-analysis model was performed to estimate the pooled prevalence of treatment failure.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The estimated pooled prevalence of treatment failure among children in Ethiopia was 12.34 (95%CI: 8.59, 16.10). Subgroup analysis of this review showed that the highest prevalence was observed in Addis Ababa (15.92%), followed by Oromia region (14.47%). Poor ART adherence (AOR = 2.53, CI: 2.03, 4.97), advanced WHO clinical staging (AOR = 1.66, CI: 1.24, 3.21), and opportunistic infections (AOR = 2.64 CI: 2.19, 4.31 were found to be significantly associated factors with childhood treatment failure.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This study revealed that treatment failure among children on ART was high in Ethiopia. Poor ART adherence, advanced WHO clinical staging, opportunistic infections, and low level of CD4 cell counts increased the risk of treatment failure.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35421084/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35421084</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC9009617/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC9009617</a> | DOI:<a href=https://doi.org/10.1371/journal.pone.0261611>10.1371/journal.pone.0261611</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35421084</guid>
      <pubDate>Thu, 14 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Belete Gelaw</dc:creator>
      <dc:creator>Lemma Dessalegn</dc:creator>
      <dc:creator>Eyasu Alem</dc:creator>
      <dc:creator>Tiwabwork Tekalign</dc:creator>
      <dc:creator>Tadele Lankirew</dc:creator>
      <dc:creator>Kirubel Eshetu</dc:creator>
      <dc:creator>Chalie Marew</dc:creator>
      <dc:creator>Bogale Chekole</dc:creator>
      <dc:creator>Amare Kassaw</dc:creator>
      <dc:date>2022-04-14</dc:date>
      <dc:source>PloS one</dc:source>
      <dc:title>Prevalence and associated factors of treatment failure among children on ART in Ethiopia: A systematic review and meta-analysis</dc:title>
      <dc:identifier>pmid:35421084</dc:identifier>
      <dc:identifier>pmc:PMC9009617</dc:identifier>
      <dc:identifier>doi:10.1371/journal.pone.0261611</dc:identifier>
    </item>
    <item>
      <title>Burden and Associated Factors of Virological Failure Among People Living with HIV in Sub-Saharan Africa: A Systematic Review and Meta-Analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35416596/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>United Nations program on HIV/AIDS 90-90-90 ambitious goal recommends 90% of people living with HIV and taking antiretroviral therapy should achieve viral suppression by 2020. However, virological failure is still a global public health problem, especially in sub-Saharan African countries. Thus, this systematic review and meta-analysis aimed at estimating the burden of virological failure and its associated factors among peoples living with HIV in sub-Saharan Africa. We searched Google Scholar,...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">AIDS Behav. 2022 Apr 13. doi: 10.1007/s10461-022-03610-y. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">United Nations program on HIV/AIDS 90-90-90 ambitious goal recommends 90% of people living with HIV and taking antiretroviral therapy should achieve viral suppression by 2020. However, virological failure is still a global public health problem, especially in sub-Saharan African countries. Thus, this systematic review and meta-analysis aimed at estimating the burden of virological failure and its associated factors among peoples living with HIV in sub-Saharan Africa. We searched Google Scholar, PubMed, Cochrane Library, and Scopus for studies that reported virologic failure and its associated factors. I-squared statistics and Egger's statistical test were used to detect heterogeneity and publication bias respectively. The pooled prevalence of virological failure was estimated using the DerSimonian-Laird random-effects model. Sensitivity analysis was done to check the presence of outlier results included in the studies. The estimated pooled prevalence of virological failure was 1.7.25%. Lower Adherence to ART drugs,longer ART duration, lower CD4 count,and being co-infected with TB were significantly associated with the pooled estimate of virological failure.Virological failure was found to be high in sub-Saharan Africa. Adherence, duration of ART, CD4 + count, and TB co-infection were the significant factors associated with the pooled estimate of virological failure. Therefore, to achieve the 90-90-90 target and sustainable development goal 3 policymakers should design mechanisms to improve ART adherence, and early detecting and prevent opportunistic infections such as TB.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35416596/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35416596</a> | DOI:<a href=https://doi.org/10.1007/s10461-022-03610-y>10.1007/s10461-022-03610-y</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35416596</guid>
      <pubDate>Wed, 13 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Chilot Desta Agegnehu</dc:creator>
      <dc:creator>Masresha Asmare Techane</dc:creator>
      <dc:creator>Abraham Tarekegn Mersha</dc:creator>
      <dc:creator>Kendalem Asmare Atalell</dc:creator>
      <dc:date>2022-04-13</dc:date>
      <dc:source>AIDS and behavior</dc:source>
      <dc:title>Burden and Associated Factors of Virological Failure Among People Living with HIV in Sub-Saharan Africa: A Systematic Review and Meta-Analysis</dc:title>
      <dc:identifier>pmid:35416596</dc:identifier>
      <dc:identifier>doi:10.1007/s10461-022-03610-y</dc:identifier>
    </item>
    <item>
      <title>Baseline physical activity is associated with reduced mortality and disease outcomes in COVID-19: A systematic review and meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35416354/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>Among coronavirus disease 2019 (COVID-19) patients, physically active individuals may be at lower risk of fatal outcomes. However, to date, no meta-analysis has been carried out to investigate the relationship between physical activity (PA) and fatal outcomes in patients with COVID-19. Therefore, this meta-analysis aims to explore the hospitalisation, intensive care unit (ICU) admissions, and mortality rates of COVID-19 patients with a history of PA participation before the onset of the...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Rev Med Virol. 2022 Apr 13:e2349. doi: 10.1002/rmv.2349. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Among coronavirus disease 2019 (COVID-19) patients, physically active individuals may be at lower risk of fatal outcomes. However, to date, no meta-analysis has been carried out to investigate the relationship between physical activity (PA) and fatal outcomes in patients with COVID-19. Therefore, this meta-analysis aims to explore the hospitalisation, intensive care unit (ICU) admissions, and mortality rates of COVID-19 patients with a history of PA participation before the onset of the pandemic, and to evaluate the reliability of the evidence. A systematic search of MEDLINE/PubMed, Cumulative Index to Nursing and Allied Health Literature, Scopus, and medRxiv was conducted for articles published up to January 2022. A random-effects meta-analysis was performed to compare disease severity and mortality rates of COVID-19 patients in physically active and inactive cases. Twelve studies involving 1,256,609 patients (991,268 physically active and 265,341 inactive cases) with COVID-19, were included in the pooled analysis. The overall meta-analysis compared with inactive controls showed significant associations between PA with reduction in COVID-19 hospitalisation (risk ratio (RR) = 0.58, 95% confidence intervals (CI) 0.46-0.73, P = 0.001), ICU admissions (RR = 0.65, 95% CI 0.52-0.81, P = 0.001) and mortality (RR = 0.47, 95% CI 0.38-0.59, P = 0.001). The protective effect of PA on COVID-19 hospitalisation and mortality could be attributable to the types of exercise such as resistance exercise (RR = 0.27, 95% CI 0.15-0.49, P = 0.001) and endurance exercise (RR = 0.41, 95% CI 0.23-0.74, P = 0.003), respectively. Physical activity is associated with decreased hospitalisation, ICU admissions, and mortality rates of patients with COVID-19. Moreover, COVID-19 patients with a history of resistance and endurance exercises experience a lower rate of hospitalisation and mortality, respectively. Further studies are warranted to determine the biological mechanisms underlying these findings.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35416354/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35416354</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC9111124/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC9111124</a> | DOI:<a href=https://doi.org/10.1002/rmv.2349>10.1002/rmv.2349</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35416354</guid>
      <pubDate>Wed, 13 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Masoud Rahmati</dc:creator>
      <dc:creator>Mahdieh Molanouri Shamsi</dc:creator>
      <dc:creator>Kayvan Khoramipour</dc:creator>
      <dc:creator>Fatemeh Malakoutinia</dc:creator>
      <dc:creator>Wongi Woo</dc:creator>
      <dc:creator>Seoyeon Park</dc:creator>
      <dc:creator>Dong Keon Yon</dc:creator>
      <dc:creator>Seung Won Lee</dc:creator>
      <dc:creator>Jae Il Shin</dc:creator>
      <dc:creator>Lee Smith</dc:creator>
      <dc:date>2022-04-13</dc:date>
      <dc:source>Reviews in medical virology</dc:source>
      <dc:title>Baseline physical activity is associated with reduced mortality and disease outcomes in COVID-19: A systematic review and meta-analysis</dc:title>
      <dc:identifier>pmid:35416354</dc:identifier>
      <dc:identifier>pmc:PMC9111124</dc:identifier>
      <dc:identifier>doi:10.1002/rmv.2349</dc:identifier>
    </item>
    <item>
      <title>Continuum of maternal healthcare services utilization and its associated factors in Ethiopia: A systematic review and meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35412408/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>The continuum of care throughout pregnancy, childbirth, and postnatal period is one of the vital strategies for improving maternal and neonatal health and preventing maternal and neonatal mortalities and morbidities. The level and determinants of the complete continuum of care for maternal health services reported by different studies were extremely varied in Ethiopia. Therefore, this meta-analysis aimed to estimate the overall prevalence of a complete continuum of maternal health care services...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Womens Health (Lond). 2022 Jan-Dec;18:17455057221091732. doi: 10.1177/17455057221091732.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The continuum of care throughout pregnancy, childbirth, and postnatal period is one of the vital strategies for improving maternal and neonatal health and preventing maternal and neonatal mortalities and morbidities. The level and determinants of the complete continuum of care for maternal health services reported by different studies were extremely varied in Ethiopia. Therefore, this meta-analysis aimed to estimate the overall prevalence of a complete continuum of maternal health care services utilization and its associated factors in Ethiopia. Databases such as PubMed/MEDLINE, Science Direct, DOJA, African journals online, Cochrane library, Google scholar, web of science, and Ethiopian universities' institutional repository were used to search for relevant studies. A total of seven studies with 4854 study participants were involved in this study. Data were extracted by two reviewers and exported to STATA Version 11 for analysis. The <i>I</i><sup>2</sup> statistics and Egger's test were used to assess heterogeneity and publication bias, respectively. The random-effects random effects model was used to estimate the level of complete continuum of care for maternal health services. The pooled prevalence of complete continuum of maternal healthcare services utilization was 25.51%. Employed mothers (OR = 3.16, 95%CI = 1.82, 5.47), first antenatal ante natal care visit before 16 weeks (OR = 7.53, 95% CI = 2.94, 19.29), birth preparedness and complication readiness plan (OR = 1.95, 95% CI = 1.12, 3.41), secondary and above educational status (OR = 2.97, 95% CI = 2.00, 4.41), planned pregnancy (OR = 6.86, 95% CI = 3.47, 13.58) and autonomy (OR = 3.73, 95% CI = 2.24-6.23) were significantly associated with continuum of maternal healthcare services utilization. In conclusion, the national level of complete continuum of maternal healthcare service utilization was low in Ethiopia. Being employed mothers, first ante natal care visit before 16 weeks, birth preparedness and complication readiness plan, secondary and above educational status, autonomy, and planned pregnancy were the major determinants of continuum of maternal healthcare services utilization.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35412408/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35412408</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC9008832/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC9008832</a> | DOI:<a href=https://doi.org/10.1177/17455057221091732>10.1177/17455057221091732</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35412408</guid>
      <pubDate>Tue, 12 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Dagne Addisu</dc:creator>
      <dc:creator>Maru Mekie</dc:creator>
      <dc:creator>Abenezer Melkie</dc:creator>
      <dc:creator>Habtamu Abie</dc:creator>
      <dc:creator>Enyew Dagnew</dc:creator>
      <dc:creator>Minale Bezie</dc:creator>
      <dc:creator>Alemu Degu</dc:creator>
      <dc:creator>Shimeles Biru</dc:creator>
      <dc:creator>Ermias Sisay Chanie</dc:creator>
      <dc:date>2022-04-12</dc:date>
      <dc:source>Women's health (London, England)</dc:source>
      <dc:title>Continuum of maternal healthcare services utilization and its associated factors in Ethiopia: A systematic review and meta-analysis</dc:title>
      <dc:identifier>pmid:35412408</dc:identifier>
      <dc:identifier>pmc:PMC9008832</dc:identifier>
      <dc:identifier>doi:10.1177/17455057221091732</dc:identifier>
    </item>
    <item>
      <title>Effect of Non-Nutritive Sucking During Heel Stick Procedure in Pain Management of Term Infants in the Neonatal Intensive Care Unit: A Systematic Review and Meta-Analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35410609/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSION: NNS effectively provides analgesia in full-term neonates undergoing heel-stick procedures; however, its effects on the long-term outcomes of infants are unclear. The results showed that NNS was effective in improving the heel stick pain in infants.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Curr Pediatr Rev. 2022 Apr 10. doi: 10.2174/1573396318666220410225908. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The objective of this study was to evaluate the efficacy of non-nutritive sucking for analgesia in term infants undergoing heel-stick procedures.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Randomized controlled trials and non-randomized studies based on the PICO framework were included in the study. Review articles, commentary, pilot, and non-English articles were excluded. Databases such as PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane were searched until January 31, 2021, using the keywords "Pain management," 'Non-nutritive sucking," and "Heel stick." All studies were reviewed and retrieved by two authors independently using a standardized form according to the inclusion criteria, and any disagreements were examined by a third scholar. Quality assessment was evaluated by using ROB-2 tool. Data were analyzed using Stata version 12.0 software, and a random-effects model was used for analysis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: 5,629 articles were retrieved from all databases, and after screening, finally, 6 relevant articles were included in the analysis. The tools used to control pain in infants in the article included PIPP,NFCS,NIPS AND NPASS. The results showed that the pain scores were significantly lower in the NNS group compared to the control group (MD, -1.05; 95% CI, -1.53 to -0.57) and NNS had a significant effect on Oxygen Saturation (O2 Sat) increasing in newborns compared to the control group, but there were no significant reduction of the heart rate (HR) between two groups.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: NNS effectively provides analgesia in full-term neonates undergoing heel-stick procedures; however, its effects on the long-term outcomes of infants are unclear. The results showed that NNS was effective in improving the heel stick pain in infants.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35410609/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35410609</a> | DOI:<a href=https://doi.org/10.2174/1573396318666220410225908>10.2174/1573396318666220410225908</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35410609</guid>
      <pubDate>Tue, 12 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Negarin Akbari</dc:creator>
      <dc:creator>Birsen Mutlu</dc:creator>
      <dc:creator>Javad Nadali</dc:creator>
      <dc:date>2022-04-12</dc:date>
      <dc:source>Current pediatric reviews</dc:source>
      <dc:title>Effect of Non-Nutritive Sucking During Heel Stick Procedure in Pain Management of Term Infants in the Neonatal Intensive Care Unit: A Systematic Review and Meta-Analysis</dc:title>
      <dc:identifier>pmid:35410609</dc:identifier>
      <dc:identifier>doi:10.2174/1573396318666220410225908</dc:identifier>
    </item>
    <item>
      <title>Evaluation of Long-term Outcomes Associated With Preterm Exposure to Antenatal Corticosteroids: A Systematic Review and Meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35404395/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS AND RELEVANCE: Results of this study showed that exposure to a single course of antenatal corticosteroids was associated with a significantly lower risk of neurodevelopmental impairment in children with extremely preterm birth but a significantly higher risk of adverse neurocognitive and/or psychological outcomes in children with late-preterm and full-term birth, who made up approximately half of those with exposure to antenatal corticosteroids. The findings suggest a need for...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Pediatr. 2022 Apr 11:e220483. doi: 10.1001/jamapediatrics.2022.0483. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Animal studies have found that antenatal corticosteroids affect many organs across multiple stages of life. However, the long-term outcomes in human children are not well understood.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To conduct a systematic review and meta-analysis of long-term outcomes associated with preterm exposure to antenatal corticosteroids compared with no exposure in all children as well as children with preterm and full-term birth.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DATA SOURCES: Academic databases were searched for articles published from January 1, 2000, to October 29, 2021, including Ovid MEDLINE, Ovid Embase, PsycInfo, CINAHL (Cumulative Index of Nursing and Allied Health Literature), Web of Science, ClinicalTrials.gov, and Google Scholar. References of articles were also searched for relevant studies.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STUDY SELECTION: Randomized clinical trials (RCTs), quasi-RCTs, and cohort studies that assessed long-term neurodevelopmental, psychological, or other outcomes at 1 year or older in those who had preterm exposure to antenatal corticosteroids were included. No language restrictions were set.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted data using a piloted data extraction form. Data on study population, pregnancy characteristics, exposure to antenatal corticosteroids, and outcomes were collected. Preferred Reporting Items for Systematic Reviews and Meta-analyses reporting guidelines were followed, and random-effects models were used for the meta-analysis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: The primary outcome was an author-defined composite of any adverse neurodevelopmental and/or psychological disorder. The secondary outcomes included specific measures of psychological disorders; neurodevelopmental delay; and anthropometric, metabolic, and cardiorespiratory outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 30 studies met the inclusion criteria, and involved more than 1.25 million children who were at least 1 year of age when the outcomes were assessed. Exposure to a single course of antenatal corticosteroids for children with extremely preterm birth was associated with a significant reduction in risk of neurodevelopmental impairment (adjusted odds ratio, 0.69 [95% CI, 0.57-0.84]; I2 = 0%; low certainty). For children with late-preterm birth, exposure to antenatal corticosteroids was associated with a higher risk of investigation for neurocognitive disorders (n = 25 668 children; adjusted hazard ratio [aHR], 1.12 [95% CI, 1.05-1.20]; low certainty). For children with full-term birth, exposure to antenatal corticosteroids was associated with a higher risk of mental or behavioral disorders (n = 641 487 children; aHR, 1.47 [95% CI, 1.36-1.60]; low certainty) as well as proven or suspected neurocognitive disorders (n = 529 205 children; aHR, 1.16 [95% CI, 1.10-1.21]; low certainty).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: Results of this study showed that exposure to a single course of antenatal corticosteroids was associated with a significantly lower risk of neurodevelopmental impairment in children with extremely preterm birth but a significantly higher risk of adverse neurocognitive and/or psychological outcomes in children with late-preterm and full-term birth, who made up approximately half of those with exposure to antenatal corticosteroids. The findings suggest a need for caution in administering antenatal corticosteroids.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35404395/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35404395</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC9002717/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC9002717</a> | DOI:<a href=https://doi.org/10.1001/jamapediatrics.2022.0483>10.1001/jamapediatrics.2022.0483</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35404395</guid>
      <pubDate>Mon, 11 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Kiran Ninan</dc:creator>
      <dc:creator>Sugee K Liyanage</dc:creator>
      <dc:creator>Kellie E Murphy</dc:creator>
      <dc:creator>Elizabeth V Asztalos</dc:creator>
      <dc:creator>Sarah D McDonald</dc:creator>
      <dc:date>2022-04-11</dc:date>
      <dc:source>JAMA pediatrics</dc:source>
      <dc:title>Evaluation of Long-term Outcomes Associated With Preterm Exposure to Antenatal Corticosteroids: A Systematic Review and Meta-analysis</dc:title>
      <dc:identifier>pmid:35404395</dc:identifier>
      <dc:identifier>pmc:PMC9002717</dc:identifier>
      <dc:identifier>doi:10.1001/jamapediatrics.2022.0483</dc:identifier>
    </item>
    <item>
      <title>Prevalence, intensity of infection and associated risk factors of soil-transmitted helminth infections among school children at Tachgayint woreda, Northcentral Ethiopia</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35395035/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: More than one-third of the school children were infected with at least one STH species and this indicates that STHs are still a health problem among school children in the study area. Therefore, periodic deworming, implementation of different prevention strategies, and health education programs should be regularly applied in the area.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">PLoS One. 2022 Apr 8;17(4):e0266333. doi: 10.1371/journal.pone.0266333. eCollection 2022.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Soil-transmitted helminths (STH) are one of the most common infections affecting underprivileged populations in low- and middle-income countries. Ascaris lumbricoides, Trichuris trichiura, and hookworm are the three main species that infect people. School children are the most vulnerable groups for STH infections due to their practice of walking and playing barefoot, poor personal hygiene, and environmental sanitation. However, evidence is limited in the study area. So, this study aimed to assess the current prevalence, infection intensity, and associated risk factors of STHs among school children in Tachgayint woreda, Northcentral Ethiopia.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A cross-sectional study was conducted among school children of Tachgayint woreda from February to May 2021. The study participants were chosen via systematic random sampling. Stool samples were collected from 325 children and examined using the Kato-Katz technique. The data was analyzed using SPSS version 23. Binary and multivariable logistic regression analyses were used to identify the potential associated factors for STHs. An adjusted odds ratio (AOR) with a 95% confidence interval (CI) was used to measure the magnitude of the association. A P-value &lt;0.05 was considered statistically significant.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The overall prevalence of STHs in this study was 36.0% (95% CI: 30.5-41.2%). Ascaris lumbricoides are the most prevalent species 89 (27.4%) followed by hookworm 14 (4.3%) and Trichuris trichiura 10 (3.1%). All of the infected school children had light-intensity of infections with the mean of eggs per gram (EPG) being 464.53. Lack of shoe wearing habit (AOR = 4.08, 95% CI: 1.29-12.88) and having untrimmed fingernail (AOR = 1.85, 95% CI: 1.06-3.22) were identified as risk factors for STH infections.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: More than one-third of the school children were infected with at least one STH species and this indicates that STHs are still a health problem among school children in the study area. Therefore, periodic deworming, implementation of different prevention strategies, and health education programs should be regularly applied in the area.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35395035/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35395035</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8993015/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8993015</a> | DOI:<a href=https://doi.org/10.1371/journal.pone.0266333>10.1371/journal.pone.0266333</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35395035</guid>
      <pubDate>Fri, 08 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Tahir Eyayu</dc:creator>
      <dc:creator>Gashaw Yimer</dc:creator>
      <dc:creator>Lemma Workineh</dc:creator>
      <dc:creator>Tegenaw Tiruneh</dc:creator>
      <dc:creator>Meslo Sema</dc:creator>
      <dc:creator>Biruk Legese</dc:creator>
      <dc:creator>Andargachew Almaw</dc:creator>
      <dc:creator>Yenealem Solomon</dc:creator>
      <dc:creator>Birhanemaskal Malkamu</dc:creator>
      <dc:creator>Ermias Sisay Chanie</dc:creator>
      <dc:creator>Dejen Getaneh Feleke</dc:creator>
      <dc:creator>Melkamu Senbeta Jimma</dc:creator>
      <dc:creator>Seada Hassen</dc:creator>
      <dc:creator>Aragaw Tesfaw</dc:creator>
      <dc:date>2022-04-08</dc:date>
      <dc:source>PloS one</dc:source>
      <dc:title>Prevalence, intensity of infection and associated risk factors of soil-transmitted helminth infections among school children at Tachgayint woreda, Northcentral Ethiopia</dc:title>
      <dc:identifier>pmid:35395035</dc:identifier>
      <dc:identifier>pmc:PMC8993015</dc:identifier>
      <dc:identifier>doi:10.1371/journal.pone.0266333</dc:identifier>
    </item>
    <item>
      <title>Effects of cognitive-behavioural therapy on psychological, physical and social outcomes of children with cancer: A systematic review and meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35378435/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSION: Cognitive-behavioural therapy has the potential to reduce anxiety, depression and pain for children with cancer. It also shows promise in reducing behavioural distress. Although effects on stress, anger, and self-efficacy have been found to be significant, there have been limited studies on these aspects of functioning and more research is needed. The findings are drawn from heterogeneous participants and interventions, thus emphasising the need to conduct well-designed intervention...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Psychosom Res. 2022 Mar 30;157:110805. doi: 10.1016/j.jpsychores.2022.110805. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: This systematic review aimed to summarise the effects of cognitive-behavioural therapy on psychological, physical and social outcomes of children with cancer without limitations on publication date.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Thirteen English and seven Chinese electronic databases were searched from April to June 2021. Randomised control trials, quasi-experimental studies, pre-test post-test studies with a control group, factorial or cross-over designs that included children ≤18 years old and during various stages of the cancer trajectory, who have received cognitive-behavioural therapy, and reported (anxiety, depression, stress, quality of life, self-efficacy, fatigue, pain, behavioural distress, anger, and/or academic performance) were included.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Eight studies with quality of evidence ranging from low to high risk of bias were included. The results show cognitive-behavioural therapy has favourable effects on anxiety, depression, pain and behavioural distress. The meta-analysis also show that it reduces anxiety (SMD = -0.89, 95% CI (-1.45, -0.32), p &lt; 0.002), depression (SMD = -0.90, 95% CI (-1.40, -0.39), p &lt; 0.0005), and pain (SMD = -0.56, 95% CI (-1.04, -0.08), p &lt; 0.002). It also has a favourable effect on stress, anger and self-efficacy, though the results are drawn from a single study.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Cognitive-behavioural therapy has the potential to reduce anxiety, depression and pain for children with cancer. It also shows promise in reducing behavioural distress. Although effects on stress, anger, and self-efficacy have been found to be significant, there have been limited studies on these aspects of functioning and more research is needed. The findings are drawn from heterogeneous participants and interventions, thus emphasising the need to conduct well-designed intervention studies, including cancer survivors.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35378435/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35378435</a> | DOI:<a href=https://doi.org/10.1016/j.jpsychores.2022.110805>10.1016/j.jpsychores.2022.110805</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35378435</guid>
      <pubDate>Mon, 04 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Tenaw Gualu Melesse</dc:creator>
      <dc:creator>Janita Pak Chun Chau</dc:creator>
      <dc:creator>M A Nan</dc:creator>
      <dc:date>2022-04-04</dc:date>
      <dc:source>Journal of psychosomatic research</dc:source>
      <dc:title>Effects of cognitive-behavioural therapy on psychological, physical and social outcomes of children with cancer: A systematic review and meta-analysis</dc:title>
      <dc:identifier>pmid:35378435</dc:identifier>
      <dc:identifier>doi:10.1016/j.jpsychores.2022.110805</dc:identifier>
    </item>
    <item>
      <title>Lifespan and Associated Factors of Peripheral Intravenous Cannula Among Hospitalized Children in Public Hospitals of the Gurage Zone, Ethiopia, 2021</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35368745/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSION AND RECOMMENDATION: The proportion of the short lifespan of the peripheral intravenous cannula was higher in hospitalized children and health care providers better to use low concentration electrolytes, low osmotic pressure, and weak alkalinity fluid. The cannula access might be the responsibility of the health-trained staff, and conserving immediate removal upon the presence of a signal that indicates a complication.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Pediatric Health Med Ther. 2022 Mar 25;13:81-93. doi: 10.2147/PHMT.S351759. eCollection 2022.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Peripheral intravenous cannulas are routinely used in hospital-admitted children requiring intravenous therapy. The majority of peripheral IVC lines are removed before completion of therapy due to cannula complications in children. Peripheral intravenous cannula securing is a painful procedure for children, so recognizing the variables associated with the peripheral intravenous cannula lifespan would help decrease the complications and increase the duration of cannula patency.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: The main aim of this study was to determine the lifespan and associated factors of peripheral intravenous cannula among hospitalized children in Gurage zone public hospitals, Ethiopia, 2021.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We conducted an institution-based cross-sectional study design among 422 admitted children in public hospitals of the Gurage zone using a systematic random sampling technique. We collected data from interviews of parents using structured questionnaires and direct observations using checklists. The data was coded and entered into EPI-DATA version 3.1 and exported to SPSS version 25 for analysis. Bivariable and multivariable analysis was used by using a binary logistic regression model. Finally, the variables with a p-value of &lt;0.05 with a 95% confidence interval (CI) from the multivariable analysis were considered statistically significant.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: One hundred and sixty-six children (41.4%) had a short cannula lifespan (below 30 h). Multivariable logistic regression analysis showed that neonatal intensive care unit (NICU) [AOR = 4.975; 95% CI (2.811-8.805)], reason for removal (complication) [AOR = 3.277; 95% CI (1.924-5.583)], fluid [AOR = 2.285; 95% CI (1.274-4.100)], and blood transfusion [AOR = 2.407; 95% CI (1.005-5.572)] were the statistically significant variables associated with the lifespan of a peripheral intravenous cannula.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION AND RECOMMENDATION: The proportion of the short lifespan of the peripheral intravenous cannula was higher in hospitalized children and health care providers better to use low concentration electrolytes, low osmotic pressure, and weak alkalinity fluid. The cannula access might be the responsibility of the health-trained staff, and conserving immediate removal upon the presence of a signal that indicates a complication.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35368745/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35368745</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8965330/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8965330</a> | DOI:<a href=https://doi.org/10.2147/PHMT.S351759>10.2147/PHMT.S351759</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35368745</guid>
      <pubDate>Mon, 04 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Agerie Aynalem Mewahegn</dc:creator>
      <dc:creator>Betelhem Tadesse</dc:creator>
      <dc:creator>Fisha Alebel GebreEyesus</dc:creator>
      <dc:creator>Tadesse Tsehay Tarekegn</dc:creator>
      <dc:creator>Baye Tsegaye Amlak</dc:creator>
      <dc:creator>Mamo Solomon Emeria</dc:creator>
      <dc:creator>Bogale Chekole Temere</dc:creator>
      <dc:creator>Tamene Fetene Terefe</dc:creator>
      <dc:creator>Bitew Tefera Zewudie</dc:creator>
      <dc:creator>Haymanot Abebe Geletie</dc:creator>
      <dc:creator>Shegaw Tesfe Mengist</dc:creator>
      <dc:date>2022-04-04</dc:date>
      <dc:source>Pediatric health, medicine and therapeutics</dc:source>
      <dc:title>Lifespan and Associated Factors of Peripheral Intravenous Cannula Among Hospitalized Children in Public Hospitals of the Gurage Zone, Ethiopia, 2021</dc:title>
      <dc:identifier>pmid:35368745</dc:identifier>
      <dc:identifier>pmc:PMC8965330</dc:identifier>
      <dc:identifier>doi:10.2147/PHMT.S351759</dc:identifier>
    </item>
    <item>
      <title>Automatic pediatric congenital heart disease classification based on heart sound signal</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35346440/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>Congenital heart diseases (CHD) are the most common birth defects, and the early diagnosis of CHD is crucial for CHD therapy. However, there are relatively few studies on intelligent auscultation for pediatric CHD, due to the fact that effective cooperation of the patient is required for the acquisition of useable heart sounds by electronic stethoscopes, yet the quality of heart sounds in pediatric is poor compared to adults due to the factors such as crying and breath sounds. This paper...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Artif Intell Med. 2022 Apr;126:102257. doi: 10.1016/j.artmed.2022.102257. Epub 2022 Feb 19.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Congenital heart diseases (CHD) are the most common birth defects, and the early diagnosis of CHD is crucial for CHD therapy. However, there are relatively few studies on intelligent auscultation for pediatric CHD, due to the fact that effective cooperation of the patient is required for the acquisition of useable heart sounds by electronic stethoscopes, yet the quality of heart sounds in pediatric is poor compared to adults due to the factors such as crying and breath sounds. This paper presents a novel pediatric CHD intelligent auscultation method based on electronic stethoscope. Firstly, a pediatric CHD heart sound database with a total of 941 PCG signal is established. Then a segment-based heart sound segmentation algorithm is proposed, which is based on PCG segment to achieve the segmentation of cardiac cycles, and therefore can reduce the influence of local noise to the global. Finally, the accurate classification of CHD is achieved using a majority voting classifier with Random Forest and Adaboost classifier based on 84 features containing time domain and frequency domain. Experimental results show that the performance of the proposed method is competitive, and the accuracy, sensitivity, specificity and f1-score of classification for CHD are 0.953, 0.946, 0.961 and 0.953 respectively.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35346440/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35346440</a> | DOI:<a href=https://doi.org/10.1016/j.artmed.2022.102257>10.1016/j.artmed.2022.102257</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35346440</guid>
      <pubDate>Tue, 29 Mar 2022 06:00:00 -0400</pubDate>
      <dc:creator>Weize Xu</dc:creator>
      <dc:creator>Kai Yu</dc:creator>
      <dc:creator>Jingjing Ye</dc:creator>
      <dc:creator>Haomin Li</dc:creator>
      <dc:creator>Jiajia Chen</dc:creator>
      <dc:creator>Fei Yin</dc:creator>
      <dc:creator>Jingfang Xu</dc:creator>
      <dc:creator>Jihua Zhu</dc:creator>
      <dc:creator>Die Li</dc:creator>
      <dc:creator>Qiang Shu</dc:creator>
      <dc:date>2022-03-29</dc:date>
      <dc:source>Artificial intelligence in medicine</dc:source>
      <dc:title>Automatic pediatric congenital heart disease classification based on heart sound signal</dc:title>
      <dc:identifier>pmid:35346440</dc:identifier>
      <dc:identifier>doi:10.1016/j.artmed.2022.102257</dc:identifier>
    </item>
    <item>
      <title>In utero exposure to bisphenols and asthma, wheeze, and lung function in school-age children: a prospective meta-analysis of 8 European birth cohorts</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35314078/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSION: This study suggests that in utero BPA exposure may be associated with higher odds of asthma and wheeze among school-age girls.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Environ Int. 2022 Apr;162:107178. doi: 10.1016/j.envint.2022.107178. Epub 2022 Mar 18.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: In utero exposure to bisphenols, widely used in consumer products, may alter lung development and increase the risk of respiratory morbidity in the offspring. However, evidence is scarce and mostly focused on bisphenol A (BPA) only.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To examine the associations of in utero exposure to BPA, bisphenol F (BPF), and bisphenol S (BPS) with asthma, wheeze, and lung function in school-age children, and whether these associations differ by sex.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We included 3,007 mother-child pairs from eight European birth cohorts. Bisphenol concentrations were determined in maternal urine samples collected during pregnancy (1999-2010). Between 7 and 11 years of age, current asthma and wheeze were assessed from questionnaires and lung function by spirometry. Wheezing patterns were constructed from questionnaires from early to mid-childhood. We performed adjusted random-effects meta-analysis on individual participant data.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Exposure to BPA was prevalent with 90% of maternal samples containing concentrations above detection limits. BPF and BPS were found in 27% and 49% of samples. In utero exposure to BPA was associated with higher odds of current asthma (OR = 1.13, 95% CI = 1.01, 1.27) and wheeze (OR = 1.14, 95% CI = 1.01, 1.30) (p-interaction sex = 0.01) among girls, but not with wheezing patterns nor lung function neither in overall nor among boys. We observed inconsistent associations of BPF and BPS with the respiratory outcomes assessed in overall and sex-stratified analyses.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This study suggests that in utero BPA exposure may be associated with higher odds of asthma and wheeze among school-age girls.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35314078/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35314078</a> | DOI:<a href=https://doi.org/10.1016/j.envint.2022.107178>10.1016/j.envint.2022.107178</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35314078</guid>
      <pubDate>Tue, 22 Mar 2022 06:00:00 -0400</pubDate>
      <dc:creator>Alicia Abellan</dc:creator>
      <dc:creator>Sara M Mensink-Bout</dc:creator>
      <dc:creator>Raquel Garcia-Esteban</dc:creator>
      <dc:creator>Andrea Beneito</dc:creator>
      <dc:creator>Leda Chatzi</dc:creator>
      <dc:creator>Talita Duarte-Salles</dc:creator>
      <dc:creator>Mariana F Fernandez</dc:creator>
      <dc:creator>Judith Garcia-Aymerich</dc:creator>
      <dc:creator>Berit Granum</dc:creator>
      <dc:creator>Carmen Iñiguez</dc:creator>
      <dc:creator>Vincent W V Jaddoe</dc:creator>
      <dc:creator>Kurunthachalam Kannan</dc:creator>
      <dc:creator>Aitana Lertxundi</dc:creator>
      <dc:creator>Maria-Jose Lopez-Espinosa</dc:creator>
      <dc:creator>Claire Philippat</dc:creator>
      <dc:creator>Amrit K Sakhi</dc:creator>
      <dc:creator>Susana Santos</dc:creator>
      <dc:creator>Valérie Siroux</dc:creator>
      <dc:creator>Jordi Sunyer</dc:creator>
      <dc:creator>Leonardo Trasande</dc:creator>
      <dc:creator>Marina Vafeiadi</dc:creator>
      <dc:creator>Fernando Vela-Soria</dc:creator>
      <dc:creator>Tiffany C Yang</dc:creator>
      <dc:creator>Carlos Zabaleta</dc:creator>
      <dc:creator>Martine Vrijheid</dc:creator>
      <dc:creator>Liesbeth Duijts</dc:creator>
      <dc:creator>Maribel Casas</dc:creator>
      <dc:date>2022-03-22</dc:date>
      <dc:source>Environment international</dc:source>
      <dc:title>In utero exposure to bisphenols and asthma, wheeze, and lung function in school-age children: a prospective meta-analysis of 8 European birth cohorts</dc:title>
      <dc:identifier>pmid:35314078</dc:identifier>
      <dc:identifier>doi:10.1016/j.envint.2022.107178</dc:identifier>
    </item>
    <item>
      <title>Clown therapy for procedural pain in children: a systematic review and meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35294645/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSION: Clown therapy seems effective in reducing procedural pain in children, particularly for older age groups, but due to poor methodological quality and the high risk of bias of the studies included, the results obtained should be considered with caution.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur J Pediatr. 2022 Jun;181(6):2215-2225. doi: 10.1007/s00431-022-04440-9. Epub 2022 Mar 16.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Among the distraction techniques used for the non-pharmacological management of acute pediatric pain, one of the most performed is clown therapy. Despite the presence in the literature of some systematic reviews that evaluate its effectiveness, none of them examines its outcomes on procedural pain which has therefore been investigated in this study. The literature search for randomized controlled trials (RCTs) was performed on the Cochrane Library, MEDLINE, EMBASE, CINAHL, PsycINFO, Web of Science, and Scopus over a time frame ranging from each database setup date to 31 July 2021. The primary outcome was the procedural pain of children. We used the Cochrane Risk of Bias tool to assess the risk of bias of the included studies. Six RCTs were selected for this review, which included a total of 517 pediatric subjects. Children undergoing clown therapy during the venipuncture or peripheral vein cannulation procedure reported less pain than those exposed to the standard of care (SMD = -0.55; 95% CI: -1.23, 0.13) but the result was not found to be statistically significant. School-aged children and adolescent reported significantly less pain (SMD = -0.51; 95% CI: -0.92, -0.09). Compared to the standard of care, children's anxiety was significantly lower with clown therapy (SMD = -0.97; 95% CI: -1.38, -0.56).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Clown therapy seems effective in reducing procedural pain in children, particularly for older age groups, but due to poor methodological quality and the high risk of bias of the studies included, the results obtained should be considered with caution.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">WHAT IS KNOWN: • Clown therapy is one of the most used techniques in the non-pharmacological management of acute pediatric pain. • Laughter physiologically stimulates the production of beta-endorphins, substances with an effect similar to opiates.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">WHAT IS NEW: • Clown therapy seems effective in reducing procedural pain and anxiety in children. • The intervention in school-age children or adolescents produces a statistically significant decrease in the symptom.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35294645/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35294645</a> | DOI:<a href=https://doi.org/10.1007/s00431-022-04440-9>10.1007/s00431-022-04440-9</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35294645</guid>
      <pubDate>Wed, 16 Mar 2022 06:00:00 -0400</pubDate>
      <dc:creator>Viviana Fusetti</dc:creator>
      <dc:creator>Luca Re</dc:creator>
      <dc:creator>Alessandra Pigni</dc:creator>
      <dc:creator>Antonino Tallarita</dc:creator>
      <dc:creator>Silvia Cilluffo</dc:creator>
      <dc:creator>Augusto Tommaso Caraceni</dc:creator>
      <dc:creator>Maura Lusignani</dc:creator>
      <dc:date>2022-03-16</dc:date>
      <dc:source>European journal of pediatrics</dc:source>
      <dc:title>Clown therapy for procedural pain in children: a systematic review and meta-analysis</dc:title>
      <dc:identifier>pmid:35294645</dc:identifier>
      <dc:identifier>doi:10.1007/s00431-022-04440-9</dc:identifier>
    </item>
    <item>
      <title>Role of 3D printing technology in paediatric teaching and training: a systematic review</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35290958/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: 3DP models were associated with greater user satisfaction and good short-term educational outcomes, with low-quality evidence. Multicentred, randomised studies with long-term follow-up and clinically assessed outcomes are needed to fully assess their benefits in this setting.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">BMJ Paediatr Open. 2021 Dec;5(1):e001050. doi: 10.1136/bmjpo-2021-001050.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: In the UK, undergraduate paediatric training is brief, resulting in trainees with a lower paediatric knowledge base compared with other aspects of medicine. With congenital conditions being successfully treated at childhood, adult clinicians encounter and will need to understand these complex pathologies. Patient-specific 3D printed (3DP) models have been used in clinical training, especially for rarer, complex conditions. We perform a systematic review to evaluate the evidence base in using 3DP models to train paediatricians, surgeons, medical students and nurses.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Online databases PubMed, Web of Science and Embase were searched between January 2010 and April 2020 using search terms relevant to "paediatrics", "education", "training" and "3D printing". Participants were medical students, postgraduate trainees or clinical staff. Comparative studies (patient-specific 3DP models vs traditional teaching methods) and non-comparative studies were included. Outcomes gauged objective and subjective measures: test scores, time taken to complete tasks, self-reported confidence and personal preferences on 3DP models. If reported, the cost of and time taken to produce the models were noted.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: From 587 results, 15 studies fit the criteria of the review protocol, with 5/15 being randomised controlled studies and 10/15 focussing on cardiovascular conditions. Participants using 3DP models demonstrated improved test scores and faster times to complete procedures and identify anatomical landmarks compared with traditional teaching methods (2D diagrams, lectures, videos and supervised clinical events). User feedback was positive, reporting greater user self-confidence in understanding concepts with users wishing for integrated use of 3DP in regular teaching. Four studies reported the costs and times of production, which varied depending on model complexity and printer. 3DP models were cheaper than 'off-the-shelf' models available on the market and had the benefit of using real-world pathologies. These mostly non-randomised and single-centred studies did not address bias or report long-term or clinically translatable outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: 3DP models were associated with greater user satisfaction and good short-term educational outcomes, with low-quality evidence. Multicentred, randomised studies with long-term follow-up and clinically assessed outcomes are needed to fully assess their benefits in this setting.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PROSPERO REGISTRATION NUMBER: CRD42020179656.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35290958/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35290958</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8655595/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8655595</a> | DOI:<a href=https://doi.org/10.1136/bmjpo-2021-001050>10.1136/bmjpo-2021-001050</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35290958</guid>
      <pubDate>Tue, 15 Mar 2022 06:00:00 -0400</pubDate>
      <dc:creator>Ashar Asif</dc:creator>
      <dc:creator>Elgin Lee</dc:creator>
      <dc:creator>Massimo Caputo</dc:creator>
      <dc:creator>Giovanni Biglino</dc:creator>
      <dc:creator>Andrew Ian Underwood Shearn</dc:creator>
      <dc:date>2022-03-15</dc:date>
      <dc:source>BMJ paediatrics open</dc:source>
      <dc:title>Role of 3D printing technology in paediatric teaching and training: a systematic review</dc:title>
      <dc:identifier>pmid:35290958</dc:identifier>
      <dc:identifier>pmc:PMC8655595</dc:identifier>
      <dc:identifier>doi:10.1136/bmjpo-2021-001050</dc:identifier>
    </item>
    <item>
      <title>Global prevalence of acceptance of COVID-19 vaccines and associated factors in pregnant women: a systematic review and meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35285374/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSION: About half of pregnant women accepted the COVID-19 vaccine. We did not find any association between sociodemographic factors and COVID-19 vaccine acceptance. However, these findings should be considered with caution due to small number of studies and the substantial heterogeneity between them.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Expert Rev Vaccines. 2022 Mar 22:1-9. doi: 10.1080/14760584.2022.2053677. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTRODUCTION: We performed a systematic review and meta-analysis to evaluate the acceptance of a COVID-19 vaccine among pregnant women and its determinants.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHOD: We searched the bibliographic databases (Scopus, Medline, and Web of Science) for the relevant studies from 1 January 2020 to 11 July 2021. We pooled the prevalence of vaccine acceptance among pregnant women using a random-effects model and conducted subgroup analyses to explore its determinants. The result was expressed as a pooled prevalence percentage and adjusted odds ratio (aOR) with 95% CIs.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS:  We found ten studies that were suitable, with 16, 696 participants from 32 countries. COVID-19 vaccination acceptability in pregnant women was 54 percent globally (95% CI: 45, 62; I2= 99.05). There was no association between sociodemographic factors including age &gt;35 years (aOR: 1.17, 95%CI: 0.95, 1.43), high education (aOR: 1.03, 95%CI: 0.79, 1.35), income levels (aOR: 1.18, 95%CI: 0.80, 1.75), knowledge scores (aOR: 2.55, 95% CI: 0.78, 8.34) and COVID-19 vaccine acceptance.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: About half of pregnant women accepted the COVID-19 vaccine. We did not find any association between sociodemographic factors and COVID-19 vaccine acceptance. However, these findings should be considered with caution due to small number of studies and the substantial heterogeneity between them.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35285374/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35285374</a> | DOI:<a href=https://doi.org/10.1080/14760584.2022.2053677>10.1080/14760584.2022.2053677</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35285374</guid>
      <pubDate>Mon, 14 Mar 2022 06:00:00 -0400</pubDate>
      <dc:creator>Maryam Nikpour</dc:creator>
      <dc:creator>Mahdi Sepidarkish</dc:creator>
      <dc:creator>Shabnam Omidvar</dc:creator>
      <dc:creator>Mojgan Firouzbakht</dc:creator>
      <dc:date>2022-03-14</dc:date>
      <dc:source>Expert review of vaccines</dc:source>
      <dc:title>Global prevalence of acceptance of COVID-19 vaccines and associated factors in pregnant women: a systematic review and meta-analysis</dc:title>
      <dc:identifier>pmid:35285374</dc:identifier>
      <dc:identifier>doi:10.1080/14760584.2022.2053677</dc:identifier>
    </item>
    <item>
      <title>Active Video Games Improve Muscular Fitness and Motor Skills in Children with Overweight or Obesity</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35270330/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>(1) Background: Childhood obesity is an important public health problem. Children with overweight or obesity often tend to show the pediatric inactivity triad components; these involve exercise deficit disorder, pediatric dynapenia, and physical illiteracy. The aim of the study was to examine the influence of an active video games (AVG) intervention combined with multicomponent exercise on muscular fitness, physical activity (PA), and motor skills in children with overweight or obesity. (2)...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Int J Environ Res Public Health. 2022 Feb 24;19(5):2642. doi: 10.3390/ijerph19052642.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">(1) Background: Childhood obesity is an important public health problem. Children with overweight or obesity often tend to show the pediatric inactivity triad components; these involve exercise deficit disorder, pediatric dynapenia, and physical illiteracy. The aim of the study was to examine the influence of an active video games (AVG) intervention combined with multicomponent exercise on muscular fitness, physical activity (PA), and motor skills in children with overweight or obesity. (2) Methods: A total of 29 (13 girls) children (10.07 ± 0.84 years) with overweight or obesity were randomly allocated in the intervention group (AVG group; <i>n</i> = 21) or in the control group (CG; <i>n</i> = 8). The intervention group performed a 5-month AVG training using the Xbox 360<sup>®</sup> with the Kinect, the Nintendo Wii<sup>®</sup>, dance mats, and the BKOOL<sup>®</sup> interactive cycling simulator, combined with multicomponent exercise, performing three sessions per week. The control group continued their daily activities without modification. Weight, PA using accelerometers, and motor competence using the Test of Gross Motor Development 3<sup>rd</sup> edition were measured. Muscular fitness was evaluated through the Counter Movement Jump height, maximal isometric strength of knee extension and handgrip strength, and lean mass using Dual-energy X-ray Absorptiometry. Mann-Whitney U and Wilcoxon signed rank tests were performed. The biserial correlation coefficients (r) were calculated. Spearman's correlation coefficients among PA, muscular fitness, and motor competence variables were also calculated. (3) Results: The AVG group significantly increased their knee extension maximal isometric strength (4.22 kg; <i>p</i> &amp;lt; 0.01), handgrip strength (1.93 kg; <i>p</i> &amp;lt; 0.01), and jump height (1.60 cm; <i>p</i> &amp;lt; 0.01), while the control group only increased the knee extension maximal isometric strength (3.15 kg; <i>p</i> &amp;lt; 0.01). The AVG group improved motor competence and light physical activity (<i>p</i> &amp;lt; 0.05) and decreased sedentary time (<i>p</i> &amp;lt; 0.05). Lean mass improved in both AVG group and CG (<i>p</i> &amp;lt; 0.05). Lastly, the percentage of improvement of motor skills positively correlated with the percentage of improvement in vigorous PA (r = 0.673; <i>p</i> = 0.003) and the percentage of improvement in CMJ (r = 0.466; <i>p</i> = 0.039). (4) Conclusions: A 5-month intervention combining AVG with multicomponent training seems to have positive effects on muscle fitness, motor competence, and PA in children with overweight or obesity.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35270330/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35270330</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8910272/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8910272</a> | DOI:<a href=https://doi.org/10.3390/ijerph19052642>10.3390/ijerph19052642</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35270330</guid>
      <pubDate>Thu, 10 Mar 2022 06:00:00 -0500</pubDate>
      <dc:creator>Cristina Comeras-Chueca</dc:creator>
      <dc:creator>Lorena Villalba-Heredia</dc:creator>
      <dc:creator>Jose Luis Perez-Lasierra</dc:creator>
      <dc:creator>Jorge Marín-Puyalto</dc:creator>
      <dc:creator>Gabriel Lozano-Berges</dc:creator>
      <dc:creator>Ángel Matute-Llorente</dc:creator>
      <dc:creator>Germán Vicente-Rodríguez</dc:creator>
      <dc:creator>Alex Gonzalez-Aguero</dc:creator>
      <dc:creator>José A Casajús</dc:creator>
      <dc:date>2022-03-10</dc:date>
      <dc:source>International journal of environmental research and public health</dc:source>
      <dc:title>Active Video Games Improve Muscular Fitness and Motor Skills in Children with Overweight or Obesity</dc:title>
      <dc:identifier>pmid:35270330</dc:identifier>
      <dc:identifier>pmc:PMC8910272</dc:identifier>
      <dc:identifier>doi:10.3390/ijerph19052642</dc:identifier>
    </item>
    <item>
      <title>Early Feeding Practices and Celiac Disease Prevention: Protocol for an Updated and Revised Systematic Review and Meta-Analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35268015/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>Uncertainty remains in regard to when, how, and in what form gluten should be introduced into the diet, particularly of infants genetically predisposed to developing celiac disease (CD). MEDLINE (PubMed), EMBASE, and Cochrane Central Register of Controlled Trials databases will be searched from inception. Randomized controlled trials (RCTs) and observational studies (cohort, case-control, or cross-sectional studies) investigating the association between early feeding practices and the risk of CD...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Nutrients. 2022 Feb 28;14(5):1040. doi: 10.3390/nu14051040.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Uncertainty remains in regard to when, how, and in what form gluten should be introduced into the diet, particularly of infants genetically predisposed to developing celiac disease (CD). MEDLINE (PubMed), EMBASE, and Cochrane Central Register of Controlled Trials databases will be searched from inception. Randomized controlled trials (RCTs) and observational studies (cohort, case-control, or cross-sectional studies) investigating the association between early feeding practices and the risk of CD and/or CD autoimmunity will be included. In prospective studies, participants will be infants regardless of the risk of developing CD. For retrospective studies, participants will be children or adults with CD or presenting with positive serology indicative of CD. Interventions will be gluten-containing products of any type. Exposures will be breastfeeding and/or the introduction of gluten-containing products of any type. In control groups, there will be no exposure, different degrees of exposure (partial vs. exclusive breastfeeding, different amounts of gluten, etc.), or a placebo. The primary outcome measure will be CD or CD autoimmunity (i.e., anti-transglutaminase or anti-endomysial antibodies). At least two reviewers will independently assess the risk of bias using a validated risk assessment tool depending on study design. Disagreements will be resolved by discussion to achieve a consensus with the involvement of one or more additional reviewers if required. If appropriate, data will be pooled. If not, a narrative synthesis will be performed. The findings will be submitted to a peer-reviewed journal.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35268015/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35268015</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8912481/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8912481</a> | DOI:<a href=https://doi.org/10.3390/nu14051040>10.3390/nu14051040</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35268015</guid>
      <pubDate>Thu, 10 Mar 2022 06:00:00 -0500</pubDate>
      <dc:creator>Hania Szajewska</dc:creator>
      <dc:creator>Raanan Shamir</dc:creator>
      <dc:creator>Anna Chmielewska</dc:creator>
      <dc:creator>Agata Stróżyk</dc:creator>
      <dc:creator>Bartłomiej M Zalewski</dc:creator>
      <dc:creator>Renata Auricchio</dc:creator>
      <dc:creator>Sibylle Koletzko</dc:creator>
      <dc:creator>Ilma R Korponay-Szabo</dc:creator>
      <dc:creator>Luisa Mearin</dc:creator>
      <dc:creator>Caroline Meijer</dc:creator>
      <dc:creator>Carmen Ribes-Koninckx</dc:creator>
      <dc:creator>Riccardo Troncone</dc:creator>
      <dc:creator>None On Behalf Of The Preventcd Study Group</dc:creator>
      <dc:date>2022-03-10</dc:date>
      <dc:source>Nutrients</dc:source>
      <dc:title>Early Feeding Practices and Celiac Disease Prevention: Protocol for an Updated and Revised Systematic Review and Meta-Analysis</dc:title>
      <dc:identifier>pmid:35268015</dc:identifier>
      <dc:identifier>pmc:PMC8912481</dc:identifier>
      <dc:identifier>doi:10.3390/nu14051040</dc:identifier>
    </item>
    <item>
      <title>Failed induction of labor and associated factors among women undergoing induction at University of Gondar Specialized Hospital, Northwest Ethiopia</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35240999/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: One-fourth of women undergoing induction at University of Gondar Specialized Hospital had failed induction of labor. Age, residence, parity, bishop score, premature-rupture of the membrane, pregnancy-induced hypertension, and method of induction were independent predictors for failed induction of labor. The combination method of ARM with oxytocin, early detection and treatment of pregnancy-induced hypertension and premature rupture of the membrane are highly recommended for reducing...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">BMC Pregnancy Childbirth. 2022 Mar 3;22(1):175. doi: 10.1186/s12884-022-04476-7.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Induction of labor is a process of artificially initiating labor to attain vaginal birth. Despite its vital role in the reduction of maternal mortality, the failure rate of induction and its contributing factors were not well studied in Ethiopia; particularly there was a limited study in the study area. This study aimed to assess the prevalence and factors associated with failed induction of labor among women undergoing induction at University of Gondar Specialized Hospital, Northwest Ethiopia.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: An institution-based retrospective cross-sectional study was conducted among 743 women undergoing induction at University of Gondar Specialized Hospital. A systematic random sampling method was used to draw a sample and the data were retrieved from the maternity registration books and medical records. Data were cleaned and entered into EpiData version 3.1 and SPSS version 20 used for analysis. Frequencies, proportions, and summary statistics were used to describe the study population and a multivariable logistic regression model was fitted to identify factors contributing to failed induction of labor. Odds ratio with 95% confidence interval computed and level of significance declared at P-value&lt; 5%.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The prevalence of failed induction of labor was 24.4% (95% CI: 21.4, 27.9). Age ≤ 30 years (AOR = 3.7, 95% CI: 2.2,6.2), rural residence (AOR = 3.7, 95% CI: 2.4,5.8), being nulliparous (AOR = 2.1, 95% CI: 1.2,3.7), 5 or less Bishop Score (AOR = 3.4, 95% CI: 2.2,5.4), premature rupture of membrane (AOR = 2.7, 95% CI: 1.5,4.6), having pregnancy-induced hypertension (AOR = 4.0, 95% CI: 2.3,7.1), and artificial rupture of membrane with oxytocin (AOR = 0.2, 95% CI: 0.1, 0.4) were associated with failed induction of labor.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: One-fourth of women undergoing induction at University of Gondar Specialized Hospital had failed induction of labor. Age, residence, parity, bishop score, premature-rupture of the membrane, pregnancy-induced hypertension, and method of induction were independent predictors for failed induction of labor. The combination method of ARM with oxytocin, early detection and treatment of pregnancy-induced hypertension and premature rupture of the membrane are highly recommended for reducing failed induction of labor.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35240999/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35240999</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8892790/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8892790</a> | DOI:<a href=https://doi.org/10.1186/s12884-022-04476-7>10.1186/s12884-022-04476-7</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35240999</guid>
      <pubDate>Fri, 04 Mar 2022 06:00:00 -0500</pubDate>
      <dc:creator>Tsion Tadesse</dc:creator>
      <dc:creator>Nega Assefa</dc:creator>
      <dc:creator>Hirbo Shore Roba</dc:creator>
      <dc:creator>Yohannes Baye</dc:creator>
      <dc:date>2022-03-04</dc:date>
      <dc:source>BMC pregnancy and childbirth</dc:source>
      <dc:title>Failed induction of labor and associated factors among women undergoing induction at University of Gondar Specialized Hospital, Northwest Ethiopia</dc:title>
      <dc:identifier>pmid:35240999</dc:identifier>
      <dc:identifier>pmc:PMC8892790</dc:identifier>
      <dc:identifier>doi:10.1186/s12884-022-04476-7</dc:identifier>
    </item>
    <item>
      <title>The effect of the problem based learning teaching model combined with mind mapping on nursing teaching: A meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35240397/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSION: The PBL teaching model combined with mind mapping works well for nursing teaching in China. It can improve students' self-learning ability, which is conducive to Chinese nursing students mastering theoretical knowledge and improving practical abilities, and can be affected by a variety of factors in practical teaching.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Nurse Educ Today. 2022 Apr;111:105306. doi: 10.1016/j.nedt.2022.105306. Epub 2022 Feb 26.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: To evaluate the effect of the problem-based learning (PBL) teaching model combined with mind mapping on nursing teaching.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The Cochrane Library, PubMed/MEDLINE, EBSCO, OVID, Science Citation Index (SCI), China Knowledge Resource Integrated (CNKI), VIP, WF and other databases were searched for studies published from 2000 to 2021 on the application of the PBL model in nursing teaching. Literature screening and data extraction were conducted by two independent evaluators based on inclusion and exclusion criteria, and heterogeneity was analysed. A meta-analysis was performed using RevMan 5.3 software.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 1907 papers were initially retrieved, and 8 randomized controlled studies were eventually included in the meta-analysis after screening. Theoretical test scores, practical test scores, and students' self-learning ability in the experimental group were all significantly higher than those in the control group (P &lt; 0.05); however, practical test scores were highly heterogeneous (I<sup>2</sup> = 76%).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: The PBL teaching model combined with mind mapping works well for nursing teaching in China. It can improve students' self-learning ability, which is conducive to Chinese nursing students mastering theoretical knowledge and improving practical abilities, and can be affected by a variety of factors in practical teaching.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35240397/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35240397</a> | DOI:<a href=https://doi.org/10.1016/j.nedt.2022.105306>10.1016/j.nedt.2022.105306</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35240397</guid>
      <pubDate>Thu, 03 Mar 2022 06:00:00 -0500</pubDate>
      <dc:creator>Xiaolin Gao</dc:creator>
      <dc:creator>Li Wang</dc:creator>
      <dc:creator>Jianjun Deng</dc:creator>
      <dc:creator>Chaomin Wan</dc:creator>
      <dc:creator>Dezhi Mu</dc:creator>
      <dc:date>2022-03-03</dc:date>
      <dc:source>Nurse education today</dc:source>
      <dc:title>The effect of the problem based learning teaching model combined with mind mapping on nursing teaching: A meta-analysis</dc:title>
      <dc:identifier>pmid:35240397</dc:identifier>
      <dc:identifier>doi:10.1016/j.nedt.2022.105306</dc:identifier>
    </item>
    <item>
      <title>Updating the Canadian clinical practice guideline for managing pediatric obesity: a protocol</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35232814/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>BACKGROUND: Since the first national guideline for managing obesity in adults and children in Canada was published in 2007, new evidence has emerged and guideline standards have evolved. Our purpose is to describe the protocol used to update the Canadian clinical practice guideline for managing pediatric obesity.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">CMAJ Open. 2022 Mar 1;10(1):E155-E164. doi: 10.9778/cmajo.20200289. Print 2022 Jan-Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Since the first national guideline for managing obesity in adults and children in Canada was published in 2007, new evidence has emerged and guideline standards have evolved. Our purpose is to describe the protocol used to update the Canadian clinical practice guideline for managing pediatric obesity.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This guideline will update the pediatric components of the 2007 Canadian clinical practice guideline for the management of obesity. In partnership with Obesity Canada, we began preliminary work in 2019; activities are scheduled for completion in 2022. The guideline will follow standards developed by the National Academy of Medicine and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) working group. Guideline development will be informed by 5 complementary literature reviews: a scoping review that focuses on clinical assessment in pediatric obesity management and 4 systematic reviews to synthesize evidence regarding families' values and preferences as well as the safety and effectiveness of interventions (psychological and behavioural; pharmacotherapeutic; and surgical). We will use standard systematic review methodology, including summarizing and assessing the certainty of evidence and determining the strength of recommendations. Competing interests will be managed proactively according to recommendations from the Guidelines International Network. Diverse stakeholders, including families and clinicians, will be engaged throughout guideline development.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTERPRETATION: The guideline will support Canadian families and clinicians to make informed, value-sensitive and evidence-based clinical decisions related to managing pediatric obesity. The guideline and accompanying resources for end-users will be published in English and French, and we will partner with Obesity Canada to optimize dissemination using integrated and end-of-project knowledge translation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35232814/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35232814</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8896489/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8896489</a> | DOI:<a href=https://doi.org/10.9778/cmajo.20200289>10.9778/cmajo.20200289</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35232814</guid>
      <pubDate>Wed, 02 Mar 2022 06:00:00 -0500</pubDate>
      <dc:creator>Bradley C Johnston</dc:creator>
      <dc:creator>Roah Merdad</dc:creator>
      <dc:creator>Diana Sherifali</dc:creator>
      <dc:creator>Maryam Kebbe</dc:creator>
      <dc:creator>Catherine S Birken</dc:creator>
      <dc:creator>Annick Buchholz</dc:creator>
      <dc:creator>Long Ge</dc:creator>
      <dc:creator>Nicole D Gehring</dc:creator>
      <dc:creator>Stasia Hadjiyannakis</dc:creator>
      <dc:creator>Jill Hamilton</dc:creator>
      <dc:creator>Dawn Hatanaka</dc:creator>
      <dc:creator>Mélanie Henderson</dc:creator>
      <dc:creator>Tracy Lebel</dc:creator>
      <dc:creator>Sarah A Moore</dc:creator>
      <dc:creator>Katherine M Morrison</dc:creator>
      <dc:creator>Ximena Ramos Salas</dc:creator>
      <dc:creator>Meghan Sebastianski</dc:creator>
      <dc:creator>Ian S Zenlea</dc:creator>
      <dc:creator>Geoff D C Ball</dc:creator>
      <dc:date>2022-03-02</dc:date>
      <dc:source>CMAJ open</dc:source>
      <dc:title>Updating the Canadian clinical practice guideline for managing pediatric obesity: a protocol</dc:title>
      <dc:identifier>pmid:35232814</dc:identifier>
      <dc:identifier>pmc:PMC8896489</dc:identifier>
      <dc:identifier>doi:10.9778/cmajo.20200289</dc:identifier>
    </item>
    <item>
      <title>Improving In-Hospital Patient Rescue: What Are Studies on Early Warning Scores Missing? A Scoping Review</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35224506/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: Despite hundreds of EWS-related publications, most do not report details of hospital context that would inform decisions about real-world EWS adoption. To make informed decisions about whether EWS implementation improves hospital quality, decision-makers may require alternatives such as peer networks and implementation pilots nested within local health systems.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Crit Care Explor. 2022 Feb 21;4(2):e0644. doi: 10.1097/CCE.0000000000000644. eCollection 2022 Feb.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: Administrative and clinical efforts to improve hospital mortality and intensive care utilization commonly focus on patient rescue, where deteriorating patients are systematically identified and intervened upon. Patient rescue is known to depend on hospital context inclusive of technologic environment, structural features, and hospital organizational behavioral features. With widespread adoption of electronic medical records, early warning score (EWS) systems, which assign points to clinical data elements, are increasingly promoted as a tool for timely patient rescue by referencing their prediction of patient deterioration. We describe the extent to which EWS intervention studies describe the hospital environment of the intervention-details that would be critical for hospital leaders attempting to determine the real-world utility of EWSs in their own hospitals.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DATA SOURCES: We searched CINAHL, PubMed, and Scopus databases for English language EWS implementation research published between 2009 and 2021 in adult medical-surgical inpatients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STUDY SELECTION: Studies including pediatric, obstetric, psychiatric, prehospital, outpatient, step-down, or ICU patients were excluded.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DATA EXTRACTION: Two investigators independently reviewed titles/abstracts for eligibility based on prespecified exclusion criteria.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DATA SYNTHESIS: We identified 1,434 studies for title/abstract screening. In all, 352 studies underwent full-text review and 21 studies were summarized. The 21 studies (18 before-and-after, three randomized trials) detailed 1,107,883 patients across 54 hospitals. Twelve reported the staff composition of an EWS response team. Ten reported the proportion of surgical patients. One reported nursing ratios; none reported intensive care staffing with in-house critical-care physicians. None measured changes in bed utilization or availability. While 16 qualitatively described resources for education/technologic implementation, none estimated costs. None described workforce composition such as team stability or culture of safety in the hospitals.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Despite hundreds of EWS-related publications, most do not report details of hospital context that would inform decisions about real-world EWS adoption. To make informed decisions about whether EWS implementation improves hospital quality, decision-makers may require alternatives such as peer networks and implementation pilots nested within local health systems.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35224506/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35224506</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8863168/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8863168</a> | DOI:<a href=https://doi.org/10.1097/CCE.0000000000000644>10.1097/CCE.0000000000000644</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35224506</guid>
      <pubDate>Mon, 28 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Sarvie Esmaeilzadeh</dc:creator>
      <dc:creator>Conor M Lane</dc:creator>
      <dc:creator>Danielle J Gerberi</dc:creator>
      <dc:creator>Elliot Wakeam</dc:creator>
      <dc:creator>Brian W Pickering</dc:creator>
      <dc:creator>Vitaly Herasevich</dc:creator>
      <dc:creator>Joseph A Hyder</dc:creator>
      <dc:date>2022-02-28</dc:date>
      <dc:source>Critical care explorations</dc:source>
      <dc:title>Improving In-Hospital Patient Rescue: What Are Studies on Early Warning Scores Missing? A Scoping Review</dc:title>
      <dc:identifier>pmid:35224506</dc:identifier>
      <dc:identifier>pmc:PMC8863168</dc:identifier>
      <dc:identifier>doi:10.1097/CCE.0000000000000644</dc:identifier>
    </item>
    <item>
      <title>Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35217581/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CLINICAL QUESTIONS: What is the role of plasma exchange and what is the optimal dose of glucocorticoids in the first 6 months of therapy of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)? This guideline was triggered by the publication of a new randomised controlled trial.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">BMJ. 2022 Feb 25;376:e064597. doi: 10.1136/bmj-2021-064597.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CLINICAL QUESTIONS: What is the role of plasma exchange and what is the optimal dose of glucocorticoids in the first 6 months of therapy of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)? This guideline was triggered by the publication of a new randomised controlled trial.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CURRENT PRACTICE: Existing guideline recommendations vary regarding the use of plasma exchange in AAV and lack explicit recommendations regarding the tapering regimen of glucocorticoids during induction therapy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RECOMMENDATIONS: The guideline panel makes a weak recommendation against plasma exchange in patients with low or low-moderate risk of developing end stage kidney disease (ESKD), and a weak recommendation in favour of plasma exchange in patients with moderate-high or high risk of developing ESKD. For patients with pulmonary haemorrhage without renal involvement, the panel suggests not using plasma exchange (weak recommendation). The panel made a strong recommendation in favour of a reduced dose rather than standard dose regimen of glucocorticoids, which involves a more rapid taper rate and lower cumulative dose during the first six months of therapy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">HOW THIS GUIDELINE WAS CREATED: A guideline panel including patients, a care giver, clinicians, content experts, and methodologists produced these recommendations using GRADE and in adherence with standards for trustworthy guidelines. The recommendations are based on two linked systematic reviews. The panel took an individual patient perspective in the development of recommendations.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">THE EVIDENCE: The systematic review of plasma exchange identified nine randomised controlled trials (RCTs) that enrolled 1060 patients with AAV. Plasma exchange probably has little or no effect on mortality or disease relapse (moderate and low certainty). Plasma exchange probably reduces the one year risk of ESKD (approximately 0.1% reduction in those with low risk, 2.1% reduction in those with low-moderate risk, 4.6% reduction in those with moderate-high risk, and 16.0% reduction in those with high risk or requiring dialysis) but increases the risk of serious infections (approximately 2.7% increase in those with low risk, 4.9% increase in those with low-moderate risk, 8.5% increase in those with moderate-high risk, to 13.5% in high risk group) at 1 year (moderate to high certainty). The guideline panel agreed that most patients with low or low-moderate risk of developing ESKD would consider the harms to outweigh the benefits, while most of those with moderate-high or high risk would consider the benefits to outweigh the harms. For patients with pulmonary haemorrhage without kidney involvement, based on indirect evidence, plasma exchange may have little or no effect on death (very low certainty) but may have an important increase in serious infections at 1 year (approximately 6.8% increase, low certainty). The systematic review of different dose regimens of glucocorticoids identified two RCTs at low risk of bias with 704 and 140 patients respectively. A reduced dose regimen of glucocorticoid probably reduces the risk of serious infections by approximately 5.9% to 12.8% and probably does not increase the risk of ESKD at the follow-up of 6 months to longer than 1 year (moderate certainty for both outcomes).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">UNDERSTANDING THE RECOMMENDATION: The recommendations were made with the understanding that patients would place a high value on reduction in ESKD and less value on avoiding serious infections. The panel concluded that most (50-90%) of fully informed patients with AAV and with low or low-moderate risk of developing ESKD with or without pulmonary haemorrhage would decline plasma exchange, whereas most patients with moderate-high or high risk or requiring dialysis with or without pulmonary haemorrhage would choose to receive plasma exchange. The panel also inferred that the majority of fully informed patients with pulmonary haemorrhage without kidney involvement would decline plasma exchange and that all or almost all (≥90%) fully informed patients with AAV would choose a reduced dose regimen of glucocorticoids during the first 6 months of therapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35217581/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35217581</a> | DOI:<a href=https://doi.org/10.1136/bmj-2021-064597>10.1136/bmj-2021-064597</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35217581</guid>
      <pubDate>Sat, 26 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Linan Zeng</dc:creator>
      <dc:creator>Michael Walsh</dc:creator>
      <dc:creator>Gordon H Guyatt</dc:creator>
      <dc:creator>Reed A C Siemieniuk</dc:creator>
      <dc:creator>David Collister</dc:creator>
      <dc:creator>Michelle Booth</dc:creator>
      <dc:creator>Paul Brown</dc:creator>
      <dc:creator>Lesha Farrar</dc:creator>
      <dc:creator>Mark Farrar</dc:creator>
      <dc:creator>Tracy Firth</dc:creator>
      <dc:creator>Lynn A Fussner</dc:creator>
      <dc:creator>Karin Kilian</dc:creator>
      <dc:creator>Mark A Little</dc:creator>
      <dc:creator>Thomas A Mavrakanas</dc:creator>
      <dc:creator>Reem A Mustafa</dc:creator>
      <dc:creator>Maryam Piram</dc:creator>
      <dc:creator>Lisa K Stamp</dc:creator>
      <dc:creator>Yingqi Xiao</dc:creator>
      <dc:creator>Lyubov Lytvyn</dc:creator>
      <dc:creator>Thomas Agoritsas</dc:creator>
      <dc:creator>Per O Vandvik</dc:creator>
      <dc:creator>Alfred Mahr</dc:creator>
      <dc:date>2022-02-26</dc:date>
      <dc:source>BMJ (Clinical research ed.)</dc:source>
      <dc:title>Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline</dc:title>
      <dc:identifier>pmid:35217581</dc:identifier>
      <dc:identifier>doi:10.1136/bmj-2021-064597</dc:identifier>
    </item>
    <item>
      <title>The Impact of GLP1 Agonists on Bone Metabolism: A Systematic Review</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35208548/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>Background and Objectives: The association between diabetes mellitus and increased risk of bone fractures has led to the investigation of the impact of antidiabetic drugs on bone metabolism. Glucagon-like peptide-1 receptor agonists (GLP1RAs) are a relatively novel and promising class of anti-hyperglycemic drugs. In addition to their blood glucose lowering action, GLP1RAs seem to have additional pleiotropic properties such as a beneficial skeletal effect; although the underlying mechanisms are...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Medicina (Kaunas). 2022 Feb 2;58(2):224. doi: 10.3390/medicina58020224.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"><i>Background and Objectives:</i> The association between diabetes mellitus and increased risk of bone fractures has led to the investigation of the impact of antidiabetic drugs on bone metabolism. Glucagon-like peptide-1 receptor agonists (GLP1RAs) are a relatively novel and promising class of anti-hyperglycemic drugs. In addition to their blood glucose lowering action, GLP1RAs seem to have additional pleiotropic properties such as a beneficial skeletal effect; although the underlying mechanisms are not completely understood. The present systematic review summarizes current evidence about GLP1RAs and their effects on bone metabolism and fracture. <i>Methods:</i> An extensive literature search was conducted based on electronic databases namely, PubMed, Google Scholar and Cochrane Central Register of Controlled Trials (CENTRAL) through October 2019 to January 2020 for articles related to bone mineral density, diabetes mellitus and GLP1RAs. We included articles published in English. Finally, we included four randomized controlled trials, three meta-analyses, a case-control study and a population-based cohort analysis. <i>Results:</i> Based on the articles included, the animal studies indicated the salutary skeletal effects of GLP1RAs in opposition to what has been commonly observed in human studies, showing that these agents have no impact on bone mineral density (BMD) and the turnover markers. Moreover, it was demonstrated that GLP1 was not associated with fracture risk as compared to other anti-hyperglycemic drugs. <i>Conclusions:</i> Findings from this systematic review have demonstrated the neutral impact of GLP1RAs on BMD. Moreover, further double-blind randomized controlled trials are needed to draw more meaningful and significant conclusions on the efficacy of GLP1RAs on BMD.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35208548/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35208548</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8878541/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8878541</a> | DOI:<a href=https://doi.org/10.3390/medicina58020224>10.3390/medicina58020224</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35208548</guid>
      <pubDate>Fri, 25 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Ioanna Daniilopoulou</dc:creator>
      <dc:creator>Eugenia Vlachou</dc:creator>
      <dc:creator>George I Lambrou</dc:creator>
      <dc:creator>Anastasia Ntikoudi</dc:creator>
      <dc:creator>Eleni Dokoutsidou</dc:creator>
      <dc:creator>Georgia Fasoi</dc:creator>
      <dc:creator>Ourania Govina</dc:creator>
      <dc:creator>Anna Kavga</dc:creator>
      <dc:creator>Athanasios N Tsartsalis</dc:creator>
      <dc:date>2022-02-25</dc:date>
      <dc:source>Medicina (Kaunas, Lithuania)</dc:source>
      <dc:title>The Impact of GLP1 Agonists on Bone Metabolism: A Systematic Review</dc:title>
      <dc:identifier>pmid:35208548</dc:identifier>
      <dc:identifier>pmc:PMC8878541</dc:identifier>
      <dc:identifier>doi:10.3390/medicina58020224</dc:identifier>
    </item>
    <item>
      <title>Prevalence of Violence Perpetrated by Healthcare Workers in Long-Term Care: A Systematic Review and Meta-Analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35206547/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>This systematic review and meta-analysis aimed to determine the prevalence of violence perpetrated by healthcare workers (HCWs) against patients in long-term care (LTC). For this purpose, five relevant databases were searched. Two reviewers extracted data from the included articles independently and assessed their quality. Overall and subgroup random-effects pooled prevalence meta-analyses were performed. A series of meta-analyses stratified by study quality were also performed due to high...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Int J Environ Res Public Health. 2022 Feb 18;19(4):2357. doi: 10.3390/ijerph19042357.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">This systematic review and meta-analysis aimed to determine the prevalence of violence perpetrated by healthcare workers (HCWs) against patients in long-term care (LTC). For this purpose, five relevant databases were searched. Two reviewers extracted data from the included articles independently and assessed their quality. Overall and subgroup random-effects pooled prevalence meta-analyses were performed. A series of meta-analyses stratified by study quality were also performed due to high heterogeneity. Nineteen articles were included, physical restraint (22%; CI: 15-29), verbal abuse (22%; CI: 16-28), and neglect (20%; CI: 15-26) attained the highest overall prevalence, while sexual abuse was less reported (2%; CI: 1-3). The prevalence of witnessed violence is generally higher than those reported by HCWs, and patients and their relatives reported fewer cases of violence than HCWs. Differences in violence perpetrated among LTC settings were found. Neglect (64%; CI: 56-72) and financial abuse (7%; CI: 3-12) reported by HCWs were higher in home care, while verbal abuse (21%; CI: 7-39) reported by patients or their families was higher in nursing homes. Our findings highlight that violence perpetrated by HCWs toward patients represents a significant concern in LTC, suggesting the adoption of reliable monitoring approaches and provision of assistance to victims in reporting abuse.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35206547/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35206547</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8877976/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8877976</a> | DOI:<a href=https://doi.org/10.3390/ijerph19042357>10.3390/ijerph19042357</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35206547</guid>
      <pubDate>Fri, 25 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Alessio Conti</dc:creator>
      <dc:creator>Alessandro Scacchi</dc:creator>
      <dc:creator>Marco Clari</dc:creator>
      <dc:creator>Marco Scattaglia</dc:creator>
      <dc:creator>Valerio Dimonte</dc:creator>
      <dc:creator>Maria Michela Gianino</dc:creator>
      <dc:date>2022-02-25</dc:date>
      <dc:source>International journal of environmental research and public health</dc:source>
      <dc:title>Prevalence of Violence Perpetrated by Healthcare Workers in Long-Term Care: A Systematic Review and Meta-Analysis</dc:title>
      <dc:identifier>pmid:35206547</dc:identifier>
      <dc:identifier>pmc:PMC8877976</dc:identifier>
      <dc:identifier>doi:10.3390/ijerph19042357</dc:identifier>
    </item>
    <item>
      <title>Relative Effect of Extracorporeal Shockwave Therapy Alone or in Combination with Noninjective Treatments on Pain and Physical Function in Knee Osteoarthritis: A Network Meta-Analysis of Randomized Controlled Trials</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35203516/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>Extracorporeal shockwave therapy (ESWT) has been recommended for managing pain in patients with knee osteoarthritis (KOA). The difference in therapeutic effects between radial shockwave characteristics (RaSW) and focused shockwave characteristics (FoSW) with different energy levels for KOA remains controversial. The purpose of this network meta-analysis (NMA) was to identify the effects relative to the different ESWT regime and combination treatments on pain and functional outcomes in...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Biomedicines. 2022 Jan 28;10(2):306. doi: 10.3390/biomedicines10020306.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Extracorporeal shockwave therapy (ESWT) has been recommended for managing pain in patients with knee osteoarthritis (KOA). The difference in therapeutic effects between radial shockwave characteristics (RaSW) and focused shockwave characteristics (FoSW) with different energy levels for KOA remains controversial. The purpose of this network meta-analysis (NMA) was to identify the effects relative to the different ESWT regime and combination treatments on pain and functional outcomes in individuals with KOA. The randomized controlled trials (RCTs) which investigated the efficacy of RaSW, FoSW, and combination treatments in patients with KOA were identified by searches of electronic databases. The included RCTs were analyzed through NMA and risk-of-bias assessment. We analyzed 69 RCTs with a total of 21 treatment arms in the NMA. Medium-energy FoSW plus physical therapy, medium-energy acupoint RaSW plus Chinese medicine, and high-energy FoSW alone were the most effective treatments for reducing pain [standard mean difference (SMD) = -4.51], restoring function (SMD = 4.97), and decreasing joint inflammation (SMD = -5.01). Population area and study quality influenced the treatment outcomes, particularly pain. Our findings indicate that medium-energy ESWT combined with physical therapy or Chinese medicine is beneficial for treating pain and increasing function in adults with KOA.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35203516/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35203516</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8869515/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8869515</a> | DOI:<a href=https://doi.org/10.3390/biomedicines10020306>10.3390/biomedicines10020306</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35203516</guid>
      <pubDate>Fri, 25 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Chun-De Liao</dc:creator>
      <dc:creator>Yu-Yun Huang</dc:creator>
      <dc:creator>Hung-Chou Chen</dc:creator>
      <dc:creator>Tsan-Hon Liou</dc:creator>
      <dc:creator>Che-Li Lin</dc:creator>
      <dc:creator>Shih-Wei Huang</dc:creator>
      <dc:date>2022-02-25</dc:date>
      <dc:source>Biomedicines</dc:source>
      <dc:title>Relative Effect of Extracorporeal Shockwave Therapy Alone or in Combination with Noninjective Treatments on Pain and Physical Function in Knee Osteoarthritis: A Network Meta-Analysis of Randomized Controlled Trials</dc:title>
      <dc:identifier>pmid:35203516</dc:identifier>
      <dc:identifier>pmc:PMC8869515</dc:identifier>
      <dc:identifier>doi:10.3390/biomedicines10020306</dc:identifier>
    </item>
    <item>
      <title>Rehabilitation for children with chronic acquired brain injury in the Child in Context Intervention (CICI) study: study protocol for a randomized controlled trial</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35193666/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>BACKGROUND: Pediatric acquired brain injury (pABI) is associated with long-term cognitive, behavioral, social, and emotional problems, which may affect the quality of life, school, and family functioning. Yet, there is a lack of evidence-based community-centered rehabilitation programs for chronic pABI and these children do not systematically receive comprehensive rehabilitation. The Child In Context Intervention (CICI) study is a pragmatic randomized controlled trial (RCT) for children with...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Trials. 2022 Feb 22;23(1):169. doi: 10.1186/s13063-022-06048-8.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Pediatric acquired brain injury (pABI) is associated with long-term cognitive, behavioral, social, and emotional problems, which may affect the quality of life, school, and family functioning. Yet, there is a lack of evidence-based community-centered rehabilitation programs for chronic pABI and these children do not systematically receive comprehensive rehabilitation. The Child In Context Intervention (CICI) study is a pragmatic randomized controlled trial (RCT) for children with chronic pABI, which aims to evaluate the effectiveness of an individualized and goal-oriented intervention targeting everyday functioning of the child and family.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Children aged 6-16 years with MRI/CT-verified intracranial abnormalities will be included in the CICI study if they have persistent self- or parent-reported cognitive, emotional, and/or behavioral challenges 1 year or more after insult and attend school regularly. A total of 70 families will be randomized 1:1 to an intervention or a control group. The intervention consists of seven family sessions, one parent seminar, and four school sessions delivered over approximately 6 months. The parent seminar will be held in person, and the other sessions will mainly be video based. The children's and families' self-reported major challenges in everyday life will be targeted using SMART goals. Evidence-based strategies, when available, will be applied to achieve the goals, combined with psychoeducation. Goal attainment scaling (GAS) will be used to evaluate goal attainment. Data is collected at baseline and after approximately 6 and 9 months. External assessors are blinded to group allocation. Primary outcomes are parent-reported brain injury symptoms in children and parenting self-efficacy at 9 months of follow-up. Secondary outcomes include child-reported brain injury symptoms, quality of life, executive functioning in daily life, parent emotional symptoms, family functioning, and unmet family health care needs. A process evaluation will be conducted.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DISCUSSION: The current study provides an innovative approach to rehabilitation for children in the chronic phase of ABI and their families. This complex intervention may contribute to the development of evidence-based, high-quality rehabilitation for a large patient group, which is underrepresented in clinical research. It may also improve collaboration between specialized rehabilitation facilities, schools, and local health care services. Inclusion for the trial started in April 2021.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">TRIAL REGISTRATION: ClinicalTrials.gov NCT04798859 . Registered on March 15, 2021.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35193666/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35193666</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8861614/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8861614</a> | DOI:<a href=https://doi.org/10.1186/s13063-022-06048-8>10.1186/s13063-022-06048-8</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35193666</guid>
      <pubDate>Wed, 23 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Nina Rohrer-Baumgartner</dc:creator>
      <dc:creator>Ingvil Laberg Holthe</dc:creator>
      <dc:creator>Edel Jannecke Svendsen</dc:creator>
      <dc:creator>Cecilie Røe</dc:creator>
      <dc:creator>Jens Egeland</dc:creator>
      <dc:creator>Ida M H Borgen</dc:creator>
      <dc:creator>Solveig L Hauger</dc:creator>
      <dc:creator>Marit V Forslund</dc:creator>
      <dc:creator>Cathrine Brunborg</dc:creator>
      <dc:creator>Hege Prag Øra</dc:creator>
      <dc:creator>Hilde Margrete Dahl</dc:creator>
      <dc:creator>Line Kildal Bragstad</dc:creator>
      <dc:creator>Eli Marie Killi</dc:creator>
      <dc:creator>Maria Sandhaug</dc:creator>
      <dc:creator>Ingerid Kleffelgård</dc:creator>
      <dc:creator>Anine Pernille Strand-Saugnes</dc:creator>
      <dc:creator>Ingeborg Dahl-Hilstad</dc:creator>
      <dc:creator>Jennie Ponsford</dc:creator>
      <dc:creator>Laraine Winter</dc:creator>
      <dc:creator>Shari Wade</dc:creator>
      <dc:creator>Marianne Løvstad</dc:creator>
      <dc:date>2022-02-23</dc:date>
      <dc:source>Trials</dc:source>
      <dc:title>Rehabilitation for children with chronic acquired brain injury in the Child in Context Intervention (CICI) study: study protocol for a randomized controlled trial</dc:title>
      <dc:identifier>pmid:35193666</dc:identifier>
      <dc:identifier>pmc:PMC8861614</dc:identifier>
      <dc:identifier>doi:10.1186/s13063-022-06048-8</dc:identifier>
    </item>
    <item>
      <title>Promoting enteral tube feeding safety and performance in preterm infants: A systematic review</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35183863/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: The review identified seven categories of nursing practices in promoting feeding safety and performance in preterm infants receiving enteral tube feeding. Oro-motor stimulation and non-nutritive sucking can be used in clinical settings to promote feeding performance in preterm infants with enteral tube feeding. Other practices will continue to be dictated by local preferences and cost factors until more robust evidence becomes available.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Int J Nurs Stud. 2022 Apr;128:104188. doi: 10.1016/j.ijnurstu.2022.104188. Epub 2022 Feb 4.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Enteral tube feeding is commonly used in preterm infants to provide enteral nutrition. Nurses play a crucial role in promoting feeding safety and performance.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The aims of this systematic review were to identify nursing practices regarding feeding safety and performance promotion in preterm infants with enteral tube feeding and summarize evidence on the effectiveness of these practices.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A comprehensive search was performed in six databases (MEDLINE, EMBASE, CINAHL, Web of Science, Cochrane Library, and Scopus). Studies on nursing practices aimed at promoting feeding safety and performance in preterm infants with enteral tube feeding were included. Risk of bias was assessed using the revised Cochrane risk-of-bias tool for randomized trials (RoB 2) for randomized controlled studies and the tool of risk-of-bias in non-randomized studies of interventions (ROBINS-I) for non-randomized studies of interventions. A narrative synthesis strategy was employed to gather evidence and analyze data.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: 61 studies (47 randomized controlled studies and 14 quasi-experimental studies) covering seven categories of practices were included. The identified nursing practices included controlling feeding interval, selecting feeding position, monitoring gastric residual, disposing of gastric residual, managing feeding temperature, feeding promotion stimulation, and supplementary methods during the transition from tube to oral feeding. Evidence supported the effectiveness of oro-motor stimulation and non-nutritive sucking as feeding performance promotion strategies in preterm infants. Other practices were suggested to be used cautiously or recommended to be further studied due to limited evidence.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The review identified seven categories of nursing practices in promoting feeding safety and performance in preterm infants receiving enteral tube feeding. Oro-motor stimulation and non-nutritive sucking can be used in clinical settings to promote feeding performance in preterm infants with enteral tube feeding. Other practices will continue to be dictated by local preferences and cost factors until more robust evidence becomes available.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: PROSPERO database (CRD42020196256).</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35183863/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35183863</a> | DOI:<a href=https://doi.org/10.1016/j.ijnurstu.2022.104188>10.1016/j.ijnurstu.2022.104188</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35183863</guid>
      <pubDate>Sun, 20 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Tian Lin</dc:creator>
      <dc:creator>Jiale Hu</dc:creator>
      <dc:creator>Lifeng Zhang</dc:creator>
      <dc:creator>Xiuqun Qin</dc:creator>
      <dc:creator>Xuelian Liu</dc:creator>
      <dc:creator>Yutao Lan</dc:creator>
      <dc:creator>Ken Chen</dc:creator>
      <dc:creator>Tianhui You</dc:creator>
      <dc:date>2022-02-20</dc:date>
      <dc:source>International journal of nursing studies</dc:source>
      <dc:title>Promoting enteral tube feeding safety and performance in preterm infants: A systematic review</dc:title>
      <dc:identifier>pmid:35183863</dc:identifier>
      <dc:identifier>doi:10.1016/j.ijnurstu.2022.104188</dc:identifier>
    </item>
    <item>
      <title>Therapeutics effects of inhaled magnesium sulfate combined with adrenergic beta-2 agonist on children with acute asthma: Systematic review and meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35181174/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSION: This review does not support the use of inhaled MgSO4 as adjunctive therapy to B2 agonist for asthmatic children.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Pediatr Nurs. 2022 Feb 15:S0882-5963(22)00018-5. doi: 10.1016/j.pedn.2022.01.007. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM: To review the evidence on the effectiveness of inhaled magnesium sulfate (MgSO4) combined with beta-2 (B2) agonist as compared to inhaled B2 agonist alone in treating pediatric patients with moderate to severe asthma attacks METHODS: The search was conducted on five electronic databases namely the Cochrane Central Register of Controlled Trials (CENTRAL), Medline, PubMed, Science Direct, and Google Scholar.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Eight trials were included in the review. All studies involved a total of 1585 children aged 2-17 years with moderate to severe asthma attacks. The risk of bias was assessed using the Cochrane risk-of-bias tool for randomized trials. Three studies that assessed the effect of inhaled MgSO4 as adjunctive therapy on vital signs revealed no effect of inhaled MgSO4 on vital signs (SMD -0.11, 95% CI 0.27-0.04, p = 0.16, I<sup>2</sup> = 68%). Two studies that assessed the effect of inhaled MgSO4 as adjunctive therapy on asthma severity score (ASS) revealed no effect of inhaled MgSO4 on ASS (SMD 0.22, 95% CI 0.01-0.44, Z = 2.01, p = 0.04, I<sup>2</sup> = 88%). Two studies that assessed the effect of inhaled MgSO4 as adjunctive therapy on peak expiratory flow rate (PEFR) revealed a large effect of B2 agonist alone on PEFR (SMD 2.02, 95% CI 0.83-3.2, p &lt; 0.001, I<sup>2</sup> = 98%).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This review does not support the use of inhaled MgSO4 as adjunctive therapy to B2 agonist for asthmatic children.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35181174/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35181174</a> | DOI:<a href=https://doi.org/10.1016/j.pedn.2022.01.007>10.1016/j.pedn.2022.01.007</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35181174</guid>
      <pubDate>Sat, 19 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Manal Kassab</dc:creator>
      <dc:creator>Doaa Shdiefat</dc:creator>
      <dc:creator>Hikmat Hadoush</dc:creator>
      <dc:creator>Saddam Kanaan</dc:creator>
      <dc:date>2022-02-19</dc:date>
      <dc:source>Journal of pediatric nursing</dc:source>
      <dc:title>Therapeutics effects of inhaled magnesium sulfate combined with adrenergic beta-2 agonist on children with acute asthma: Systematic review and meta-analysis</dc:title>
      <dc:identifier>pmid:35181174</dc:identifier>
      <dc:identifier>doi:10.1016/j.pedn.2022.01.007</dc:identifier>
    </item>
    <item>
      <title>A scoping review of asthma and machine learning</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35171725/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: The use of ML in asthma studies has been increasing with most of this focused on the three major topics (&gt;50%). Future research using ML could focus on gaps such as a broader range of study topics and focus on its use in additional populations (e.g. location of residence).</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Asthma. 2022 Mar 2:1-13. doi: 10.1080/02770903.2022.2043364. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: The objective of this study was to determine the extent of machine learning (ML) application in asthma research and to identify research gaps while mapping the existing literature.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DATA SOURCES: We conducted a scoping review. PubMed, ProQuest, and Embase Scopus databases were searched with an end date of September 18, 2020.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STUDY SELECTION: DistillerSR was used for data management. Inclusion criteria were an asthma focus, human participants, ML techniques, and written in English. Exclusion criteria were abstract only, simulation-based, not human based, or were reviews or commentaries. Descriptive statistics were presented.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 6,317 potential articles were found. After removing duplicates, and reviewing the titles and abstracts, 102 articles were included for the full text analysis. Asthma episode prediction (24.5%), asthma phenotype classification (16.7%), and genetic profiling of asthma (12.7%) were the top three study topics. Cohort (52.9%), cross-sectional (20.6%), and case-control studies (11.8%) were the study designs most frequently used. Regarding the ML techniques, 34.3% of the studies used more than one technique. Neural networks, clustering, and random forests were the most common ML techniques used where they were used in 20.6%, 18.6%, and 17.6% of studies, respectively. Very few studies considered location of residence (i.e. urban or rural status).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The use of ML in asthma studies has been increasing with most of this focused on the three major topics (&gt;50%). Future research using ML could focus on gaps such as a broader range of study topics and focus on its use in additional populations (e.g. location of residence).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Supplemental data for this article is available online at http://dx.doi.org/ .</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35171725/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35171725</a> | DOI:<a href=https://doi.org/10.1080/02770903.2022.2043364>10.1080/02770903.2022.2043364</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35171725</guid>
      <pubDate>Wed, 16 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Ulfat A Khanam</dc:creator>
      <dc:creator>Zhiwei Gao</dc:creator>
      <dc:creator>Darryl Adamko</dc:creator>
      <dc:creator>Anthony Kusalik</dc:creator>
      <dc:creator>Donna C Rennie</dc:creator>
      <dc:creator>Donna Goodridge</dc:creator>
      <dc:creator>Luan Chu</dc:creator>
      <dc:creator>Joshua A Lawson</dc:creator>
      <dc:date>2022-02-16</dc:date>
      <dc:source>The Journal of asthma : official journal of the Association for the Care of Asthma</dc:source>
      <dc:title>A scoping review of asthma and machine learning</dc:title>
      <dc:identifier>pmid:35171725</dc:identifier>
      <dc:identifier>doi:10.1080/02770903.2022.2043364</dc:identifier>
    </item>
    <item>
      <title>Associations of early-life pet ownership with asthma and allergic sensitization: A meta-analysis of more than 77,000 children from the EU Child Cohort Network</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35150722/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSION: Our findings do not support early-life cat and dog ownership in themselves increasing the risk of school-age asthma, but they do suggest that ownership may potentially exacerbate the risks associated with cat- and dog-specific allergic sensitization.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Allergy Clin Immunol. 2022 Feb 10:S0091-6749(22)00149-X. doi: 10.1016/j.jaci.2022.01.023. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Studies examining associations of early-life cat and dog ownership with childhood asthma have reported inconsistent results. Several factors could explain these inconsistencies, including type of pet, timing, and degree of exposure.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: Our aim was to study associations of early-life cat and dog ownership with asthma in school-aged children, including the role of type (cat vs dog), timing (never, prenatal, or early childhood), and degree of ownership (number of pets owned), and the role of allergic sensitization.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We used harmonized data from 77,434 mother-child dyads from 9 birth cohorts in the European Union Child Cohort Network when the child was 5 to 11 years old. Associations were examined through the DataSHIELD platform by using adjusted logistic regression models, which were fitted separately for each cohort and combined by using random effects meta-analysis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The prevalence of early-life cat and dog ownership ranged from 12% to 45% and 7% to 47%, respectively, and the prevalence of asthma ranged from 2% to 20%. There was no overall association between either cat or dog ownership and asthma (odds ratio [OR] = 0.97 [95% CI = 0.87-1.09] and 0.92 [95% CI = 0.85-1.01], respectively). Timing and degree of ownership did not strongly influence associations. Cat and dog ownership were also not associated with cat- and dog-specific allergic sensitization (OR = 0.92 [95% CI = 0.75-1.13] and 0.93 [95% CI = 0.57-1.54], respectively). However, cat- and dog-specific allergic sensitization was strongly associated with school-age asthma (OR = 6.69 [95% CI = 4.91-9.10] and 5.98 [95% CI = 3.14-11.36], respectively). There was also some indication of an interaction between ownership and sensitization, suggesting that ownership may exacerbate the risks associated with pet-specific sensitization but offer some protection against asthma in the absence of sensitization.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Our findings do not support early-life cat and dog ownership in themselves increasing the risk of school-age asthma, but they do suggest that ownership may potentially exacerbate the risks associated with cat- and dog-specific allergic sensitization.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35150722/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35150722</a> | DOI:<a href=https://doi.org/10.1016/j.jaci.2022.01.023>10.1016/j.jaci.2022.01.023</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35150722</guid>
      <pubDate>Sat, 12 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Angela Pinot de Moira</dc:creator>
      <dc:creator>Katrine Strandberg-Larsen</dc:creator>
      <dc:creator>Tom Bishop</dc:creator>
      <dc:creator>Marie Pedersen</dc:creator>
      <dc:creator>Demetris Avraam</dc:creator>
      <dc:creator>Tim Cadman</dc:creator>
      <dc:creator>Lucinda Calas</dc:creator>
      <dc:creator>Maribel Casas</dc:creator>
      <dc:creator>Blandine de Lauzon Guillain</dc:creator>
      <dc:creator>Ahmed Elhakeem</dc:creator>
      <dc:creator>Ana Esplugues</dc:creator>
      <dc:creator>Marisa Estarlich</dc:creator>
      <dc:creator>Rachel E Foong</dc:creator>
      <dc:creator>Sido Haakma</dc:creator>
      <dc:creator>Jennifer R Harris</dc:creator>
      <dc:creator>Rae-Chi Huang</dc:creator>
      <dc:creator>Hazel Inskip</dc:creator>
      <dc:creator>Aitana Lertxundi</dc:creator>
      <dc:creator>Sara M Mensink-Bout</dc:creator>
      <dc:creator>Johanna L T Nader</dc:creator>
      <dc:creator>Costanza Pizzi</dc:creator>
      <dc:creator>Maja Popovic</dc:creator>
      <dc:creator>Theodosia Salika</dc:creator>
      <dc:creator>Jordi Sunyer</dc:creator>
      <dc:creator>Evelien R Van Meel</dc:creator>
      <dc:creator>Morris A Swertz</dc:creator>
      <dc:creator>Vincent W V Jaddoe</dc:creator>
      <dc:creator>Paul Burton</dc:creator>
      <dc:creator>Liesbeth Duijts</dc:creator>
      <dc:creator>Anne-Marie Nybo Andersen</dc:creator>
      <dc:date>2022-02-12</dc:date>
      <dc:source>The Journal of allergy and clinical immunology</dc:source>
      <dc:title>Associations of early-life pet ownership with asthma and allergic sensitization: A meta-analysis of more than 77,000 children from the EU Child Cohort Network</dc:title>
      <dc:identifier>pmid:35150722</dc:identifier>
      <dc:identifier>doi:10.1016/j.jaci.2022.01.023</dc:identifier>
    </item>
    <item>
      <title>Myocardial Deformation Imaging by Speckle-Tracking Echocardiography for Assessment of Cardiotoxicity in Children during and after Chemotherapy: A Systematic Review and Meta-Analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35149208/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: Myocardial strain imaging by speckle-tracking echocardiography unveils early evidence of myocardial injury in children with cancer and long-term CCS. To support its adoption for clinical use, more data are required for the better understating of myocardial deformation parameters in the risk stratification of children with cancer and prediction of development of cardiomyopathy among CCS.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Soc Echocardiogr. 2022 Feb 8:S0894-7317(22)00056-6. doi: 10.1016/j.echo.2022.01.017. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Children with cancer and childhood cancer survivors (CCS) are at risk for developing chemotherapy-induced cardiomyopathy. Myocardial deformation imaging has shown potential in the early detection of subclinical myocardial damage with implications on therapeutic interventions and improvement of outcomes. The aim of this study was to perform a systemic review and meta-analysis of literature on the assessment of left ventricular and right ventricular myocardial deformation by speckle-tracking echocardiography at rest and during stress in children with cancer during and in survivors after chemotherapy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A systematic review was performed through searching MEDLINE, Embase, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Central Register of Controlled Trials, and Scopus. Search hedges were created to cover the concepts of childhood cancer, chemotherapy, radiotherapy, anthracycline, cardiotoxicity, speckle-tracking, myocardial strain, and myocardial deformation. Two independent investigators reviewed the eligibility of articles for inclusion. The weighted mean difference in ventricular strain between pre- and postchemotherapy treatment and that between long-term CCS and healthy subjects were estimated using random-effect models with 95% CIs. Heterogeneity and publication bias were assessed using I<sup>2</sup> statistics and the Egger test, respectively.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of the total of 8,703 records initially identified, 42 studies with a total of 5,430 children with cancer were included. Of these 42 studies that showed heterogeneities, nine assessed early myocardial injury during chemotherapy, 30 assessed late myocardial injury after chemotherapy with no publication bias, and three studied myocardial mechanics during stress. The main findings were as follows: (1) left ventricular systolic deformation is impaired in children with cancer during the initial treatment phase and among long-term CCS, while data on changes in right ventricular deformation are limited and inconclusive; (2) the predictive value of early reduction of myocardial strain imaging in forecasting subsequent development of cardiotoxicity is unknown, as it has not been studied; (3) limited data suggest the possibility of impaired left ventricular contractile mechanics during stress in CCS; and (4) cumulative anthracycline dose and chest-directed radiotherapy are consistently identified as factors associated with impaired myocardial deformation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Myocardial strain imaging by speckle-tracking echocardiography unveils early evidence of myocardial injury in children with cancer and long-term CCS. To support its adoption for clinical use, more data are required for the better understating of myocardial deformation parameters in the risk stratification of children with cancer and prediction of development of cardiomyopathy among CCS.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35149208/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35149208</a> | DOI:<a href=https://doi.org/10.1016/j.echo.2022.01.017>10.1016/j.echo.2022.01.017</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35149208</guid>
      <pubDate>Sat, 12 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Vivian Wing-Yi Li</dc:creator>
      <dc:creator>Edwina Kam-Fung So</dc:creator>
      <dc:creator>Wilfred Hing-Sang Wong</dc:creator>
      <dc:creator>Yiu-Fai Cheung</dc:creator>
      <dc:date>2022-02-12</dc:date>
      <dc:source>Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography</dc:source>
      <dc:title>Myocardial Deformation Imaging by Speckle-Tracking Echocardiography for Assessment of Cardiotoxicity in Children during and after Chemotherapy: A Systematic Review and Meta-Analysis</dc:title>
      <dc:identifier>pmid:35149208</dc:identifier>
      <dc:identifier>doi:10.1016/j.echo.2022.01.017</dc:identifier>
    </item>
    <item>
      <title>Willingness to join community based health insurance among households in South Wollo, Northeast Ethiopia: A community-based cross-sectional study</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35143509/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSION: Nearly three-fourths of the households were willing to join community-based health insurance programs. However, different household and health service-related factors affected their willingness. The ministry of health with the regional and woreda health offices should work towards improving the quality of health services, conduct program advocacy and community sensitization towards the program, and build trust with the community.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">PLoS One. 2022 Feb 10;17(2):e0261642. doi: 10.1371/journal.pone.0261642. eCollection 2022.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Poor health care financing remains a major challenge to health service utilization among the lower socioeconomic society. Consequently, countries have designed different health insurance programs to overcome financial barriers against health services utilization. Similarly, Ethiopia has been implementing community-based health insurance programs since 2011 to improve health care financing system. However, only a small number of people are enrolled which might be attributed to lack of willingness towards the program and the reasons for this remained under reported. This study was intended to examine willingness to join the community-based health insurance program and its associated factors in South Wollo, Northeast Ethiopia.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHOD: A community-based cross-sectional study was conducted among 421 households. A multistage systematic random sampling technique was employed to recruit the study households. Data were entered into EpiData version 3.1 and was exported into SPSS version 24.0 for analysis. Bivariable and multivariable logistic regression analysis with a backward elimination method was performed to identify the determinants of willingness to join community-based health insurance. Finally, a statistically significant level was declared at a p-value of less than 0.05.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Two hundred and ninety-three [73.6% (95%CI:68.8%-77.9%)] households were willing to join community-based health insurance programs. Being male headed household (AOR:0.2, 95%CI: 0.07-0.58), being a member of Idir (AOR:0.46, 95%CI: 0.25-.84), absence of chronic illness in the household (AOR: 0.31, 95%CI: 0.13-0.77), and family size &lt; 4 (AOR: 0.18, 95% CI:0.08-0.41) were barriers to join community-based health insurance program whereas rural residency (AOR:1.9, 95% CI: 1.09-3.32), perceived quality health services (AOR:2.96, 95%CI:1.4-6.24), and having positive attitude (AOR:4.1, 95%CI:2.32-7.22) and good knowledge to programs (AOR:2.62, 95%CI:1.43-4.8) were enabling factors.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Nearly three-fourths of the households were willing to join community-based health insurance programs. However, different household and health service-related factors affected their willingness. The ministry of health with the regional and woreda health offices should work towards improving the quality of health services, conduct program advocacy and community sensitization towards the program, and build trust with the community.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35143509/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35143509</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8830733/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">PMC8830733</a> | DOI:<a href=https://doi.org/10.1371/journal.pone.0261642>10.1371/journal.pone.0261642</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35143509</guid>
      <pubDate>Thu, 10 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Gebeyaw Biset Wagaw</dc:creator>
      <dc:creator>Abay Woday Tadesse</dc:creator>
      <dc:creator>Getahun Yeshiwas Ambaye</dc:creator>
      <dc:date>2022-02-10</dc:date>
      <dc:source>PloS one</dc:source>
      <dc:title>Willingness to join community based health insurance among households in South Wollo, Northeast Ethiopia: A community-based cross-sectional study</dc:title>
      <dc:identifier>pmid:35143509</dc:identifier>
      <dc:identifier>pmc:PMC8830733</dc:identifier>
      <dc:identifier>doi:10.1371/journal.pone.0261642</dc:identifier>
    </item>
    <item>
      <title>Systematic review of the efficacy, effectiveness and safety of MF59&lt;sup&gt;®&lt;/sup&gt; adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35142401/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>The most effective means of preventing seasonal influenza is through vaccination. In this systematic review, we investigated the efficacy, effectiveness and safety of MF59^(®) adjuvanted trivalent and quadrivalent influenza vaccines to prevent laboratory-confirmed influenza. A systematic literature search was conducted in electronic databases and grey literature sources up to 7 February 2020. Randomised controlled trials and non-randomised studies of interventions (NRSIs) were eligible for...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Rev Med Virol. 2022 Feb 10:e2329. doi: 10.1002/rmv.2329. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The most effective means of preventing seasonal influenza is through vaccination. In this systematic review, we investigated the efficacy, effectiveness and safety of MF59<sup>®</sup> adjuvanted trivalent and quadrivalent influenza vaccines to prevent laboratory-confirmed influenza. A systematic literature search was conducted in electronic databases and grey literature sources up to 7 February 2020. Randomised controlled trials and non-randomised studies of interventions (NRSIs) were eligible for inclusion. The search returned 28,846 records, of which 48 studies on MF59<sup>®</sup> adjuvanted vaccines met our inclusion criteria. No efficacy trials were identified. In terms of vaccine effectiveness (VE), MF59<sup>®</sup> adjuvanted trivalent influenza vaccines were effective in preventing laboratory-confirmed influenza in older adults (aged ≥65 years) compared with no vaccination (VE = 45%, 95% confidence interval (CI) 23%-61%, 5 NRSIs across 3 influenza seasons). By subtype, significant effect was found for influenza A(H1N1) (VE = 61%, 95% CI 44%-73%) and B (VE = 29%, 95% CI 5%-46%), but not for A(H3N2). In terms of relative VE, there was no significant difference comparing MF59<sup>®</sup> adjuvanted trivalent vaccines with either non-adjuvanted trivalent or quadrivalent vaccines. Compared with traditional trivalent influenza vaccines, MF59<sup>®</sup> adjuvanted trivalent influenza vaccines were associated with a greater number of local adverse events (RR = 1.90, 95% CI 1.50-2.39) and systemic reactions (RR = 1.18, 95% CI 1.02-1.38). In conclusion, MF59<sup>®</sup> adjuvanted trivalent influenza vaccines were found to be more effective than 'no vaccination'. Based on limited data, there was no significant difference comparing the effectiveness of MF59<sup>®</sup> adjuvanted vaccines with their non-adjuvanted counterparts.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35142401/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35142401</a> | DOI:<a href=https://doi.org/10.1002/rmv.2329>10.1002/rmv.2329</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35142401</guid>
      <pubDate>Thu, 10 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Eamon O Murchu</dc:creator>
      <dc:creator>Laura Comber</dc:creator>
      <dc:creator>Karen Jordan</dc:creator>
      <dc:creator>Sarah Hawkshaw</dc:creator>
      <dc:creator>Liam Marshall</dc:creator>
      <dc:creator>Michelle O'Neill</dc:creator>
      <dc:creator>Máirín Ryan</dc:creator>
      <dc:creator>Conor Teljeur</dc:creator>
      <dc:creator>Annasara Carnahan</dc:creator>
      <dc:creator>Jaime Jesús Pérez</dc:creator>
      <dc:creator>Anna Hayman Robertson</dc:creator>
      <dc:creator>Kari Johansen</dc:creator>
      <dc:creator>Jorgen de Jonge</dc:creator>
      <dc:creator>Tyra Krause</dc:creator>
      <dc:creator>Nathalie Nicolay</dc:creator>
      <dc:creator>Hanna Nohynek</dc:creator>
      <dc:creator>Ioanna Pavlopoulou</dc:creator>
      <dc:creator>Richard Pebody</dc:creator>
      <dc:creator>Pasi Penttinen</dc:creator>
      <dc:creator>Marta Soler-Soneira</dc:creator>
      <dc:creator>Ole Wichmann</dc:creator>
      <dc:creator>Patricia Harrington</dc:creator>
      <dc:date>2022-02-10</dc:date>
      <dc:source>Reviews in medical virology</dc:source>
      <dc:title>Systematic review of the efficacy, effectiveness and safety of MF59&lt;sup&gt;®&lt;/sup&gt; adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age</dc:title>
      <dc:identifier>pmid:35142401</dc:identifier>
      <dc:identifier>doi:10.1002/rmv.2329</dc:identifier>
    </item>
    <item>
      <title>Systematic review of the efficacy, effectiveness and safety of cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35137512/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>The most effective means of preventing seasonal influenza is through strain-specific vaccination. In this study, we investigated the efficacy, effectiveness and safety of cell-based trivalent and quadrivalent influenza vaccines. A systematic literature search was conducted in electronic databases and grey literature sources up to 7 February 2020. Randomised controlled trials (RCTs) and non-randomised studies of interventions (NRSIs) were eligible for inclusion. Two reviewers independently...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Rev Med Virol. 2022 Feb 8:e2332. doi: 10.1002/rmv.2332. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The most effective means of preventing seasonal influenza is through strain-specific vaccination. In this study, we investigated the efficacy, effectiveness and safety of cell-based trivalent and quadrivalent influenza vaccines. A systematic literature search was conducted in electronic databases and grey literature sources up to 7 February 2020. Randomised controlled trials (RCTs) and non-randomised studies of interventions (NRSIs) were eligible for inclusion. Two reviewers independently screened, extracted data and assessed the risk of bias of included studies. Certainty of evidence for key outcomes was assessed using the GRADE methodology. The search returned 28,846 records, of which 868 full-text articles were assessed for relevance. Of these, 19 studies met the inclusion criteria. No relative efficacy data were identified for the direct comparison of cell-based vaccines compared with traditional vaccines (egg-based). Efficacy data were available comparing cell-based trivalent influenza vaccines with placebo in adults (aged 18-49 years). Overall vaccine efficacy was 70% against any influenza subtype (95% CI 61%-77%, two RCTS), 82% against influenza A(H1N1) (95% CI 71%-89%, 2 RCTs), 72% against influenza A(H3N2) (95% CI 39%-87%, 2 RCTs) and 52% against influenza B (95% CI 30%-68%, 2 RCTs). Limited and heterogeneous data were presented for effectiveness when compared with no vaccination. One NRSI compared cell-based trivalent and quadrivalent vaccination with traditional trivalent and quadrivalent vaccination, finding a small but significant difference in favour of cell-based vaccines for influenza-related hospitalisation, hospital encounters and physician office visits. The safety profile of cell-based trivalent vaccines was comparable to traditional trivalent influenza vaccines. Compared with placebo, cell-based trivalent influenza vaccines have demonstrated greater efficacy in adults aged 18-49 years. Overall cell-based vaccines are well-tolerated in adults, however, evidence regarding the effectiveness of these vaccines compared with traditional seasonal influenza vaccines is limited.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35137512/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35137512</a> | DOI:<a href=https://doi.org/10.1002/rmv.2332>10.1002/rmv.2332</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35137512</guid>
      <pubDate>Wed, 09 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Karen Jordan</dc:creator>
      <dc:creator>Eamon O Murchu</dc:creator>
      <dc:creator>Laura Comber</dc:creator>
      <dc:creator>Sarah Hawkshaw</dc:creator>
      <dc:creator>Liam Marshall</dc:creator>
      <dc:creator>Michelle O'Neill</dc:creator>
      <dc:creator>Conor Teljeur</dc:creator>
      <dc:creator>Patricia Harrington</dc:creator>
      <dc:creator>Annasara Carnahan</dc:creator>
      <dc:creator>Jaime Jesús Pérez-Martín</dc:creator>
      <dc:creator>Anna Hayman Robertson</dc:creator>
      <dc:creator>Kari Johansen</dc:creator>
      <dc:creator>Jorgen de Jonge</dc:creator>
      <dc:creator>Tyra Krause</dc:creator>
      <dc:creator>Nathalie Nicolay</dc:creator>
      <dc:creator>Hanna Nohynek</dc:creator>
      <dc:creator>Ioanna Pavlopoulou</dc:creator>
      <dc:creator>Richard Pebody</dc:creator>
      <dc:creator>Pasi Penttinen</dc:creator>
      <dc:creator>Marta Soler-Soneira</dc:creator>
      <dc:creator>Ole Wichmann</dc:creator>
      <dc:creator>Máirín Ryan</dc:creator>
      <dc:date>2022-02-09</dc:date>
      <dc:source>Reviews in medical virology</dc:source>
      <dc:title>Systematic review of the efficacy, effectiveness and safety of cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age</dc:title>
      <dc:identifier>pmid:35137512</dc:identifier>
      <dc:identifier>doi:10.1002/rmv.2332</dc:identifier>
    </item>
    <item>
      <title>A scoping review of outcomes commonly reported in obesity prevention interventions aiming to improve obesity-related health behaviors in children to age 5 years</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35122457/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>This scoping review was undertaken as the first stage of development of the Core Outcome Sets for Early Prevention of Obesity in CHildhood (COS-EPOCH). The aim of this review is to identify the outcomes collected and reported in randomized controlled trials of early childhood obesity prevention interventions. A systematic scoping review was undertaken following published guidelines. Trial registries and Medline were searched, and records retrieved were screened by two reviewers. Included trials...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Obes Rev. 2022 May;23(5):e13427. doi: 10.1111/obr.13427. Epub 2022 Feb 5.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">This scoping review was undertaken as the first stage of development of the Core Outcome Sets for Early Prevention of Obesity in CHildhood (COS-EPOCH). The aim of this review is to identify the outcomes collected and reported in randomized controlled trials of early childhood obesity prevention interventions. A systematic scoping review was undertaken following published guidelines. Trial registries and Medline were searched, and records retrieved were screened by two reviewers. Included trials aimed to prevent childhood obesity in the first 5 years of life and were randomized. Data were extracted using a standardized form. Outcomes were assigned to outcome domains, and similar definitions within each domain were merged, based on key literature and expert consensus. Outcome and domain frequencies were estimated and presented in outcome matrices. Eighteen outcome domains were identified from 161 included studies: "anthropometry," "dietary intake," "physical activity," "sedentary behaviour," "emotional functioning/wellbeing," "feeding," "cognitive/executive functioning," "sleep," "other," "study-related," "parenting practices," "motor skill development," "environmental," "blood and lymphatic system," "perceptions and preferences," "quality of life," and "economic," "oral health." The most frequently reported outcome domain was anthropometry (92% of studies), followed by dietary intake (77%) and physical activity (60%). 221 unique outcomes were identified, indicating a high degree of heterogeneity. Body mass index was the only outcome reported in &gt;50% of studies. The considerable heterogeneity in outcomes supports the need for the development of COS-EPOCH.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35122457/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35122457</a> | DOI:<a href=https://doi.org/10.1111/obr.13427>10.1111/obr.13427</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35122457</guid>
      <pubDate>Sat, 05 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Vicki Brown</dc:creator>
      <dc:creator>Marj Moodie</dc:creator>
      <dc:creator>Marufa Sultana</dc:creator>
      <dc:creator>Kylie E Hunter</dc:creator>
      <dc:creator>Rebecca Byrne</dc:creator>
      <dc:creator>Dorota Zarnowiecki</dc:creator>
      <dc:creator>Anna Lene Seidler</dc:creator>
      <dc:creator>Rebecca Golley</dc:creator>
      <dc:creator>Rachael W Taylor</dc:creator>
      <dc:creator>Kylie D Hesketh</dc:creator>
      <dc:creator>Karen Matvienko-Sikar</dc:creator>
      <dc:date>2022-02-05</dc:date>
      <dc:source>Obesity reviews : an official journal of the International Association for the Study of Obesity</dc:source>
      <dc:title>A scoping review of outcomes commonly reported in obesity prevention interventions aiming to improve obesity-related health behaviors in children to age 5 years</dc:title>
      <dc:identifier>pmid:35122457</dc:identifier>
      <dc:identifier>doi:10.1111/obr.13427</dc:identifier>
    </item>
    <item>
      <title>2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35119438/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&amp;fc=None&amp;ff=20220524175129&amp;v=2.17.6</link>
      <description>CONCLUSIONS: The current guidelines represent a comprehensive list of practical clinical recommendations for the assessment, prevention, and management of key aspects for the comprehensive critical care of infants and children. Main areas of focus included 1) need for the routine monitoring of pain, agitation, withdrawal, and delirium using validated tools, 2) enhanced use of protocolized sedation and analgesia, and 3) recognition of the importance of nonpharmacologic interventions for enhancing...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Pediatr Crit Care Med. 2022 Feb 1;23(2):e74-e110. doi: 10.1097/PCC.0000000000002873.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RATIONALE: A guideline that both evaluates current practice and provides recommendations to address sedation, pain, and delirium management with regard for neuromuscular blockade and withdrawal is not currently available.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To develop comprehensive clinical practice guidelines for critically ill infants and children, with specific attention to seven domains of care including pain, sedation/agitation, iatrogenic withdrawal, neuromuscular blockade, delirium, PICU environment, and early mobility.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN: The Society of Critical Care Medicine Pediatric Pain, Agitation, Neuromuscular Blockade, and Delirium in critically ill pediatric patients with consideration of the PICU Environment and Early Mobility Guideline Taskforce was comprised of 29 national experts who collaborated from 2009 to 2021 via teleconference and/or e-mail at least monthly for planning, literature review, and guideline development, revision, and approval. The full taskforce gathered annually in-person during the Society of Critical Care Medicine Congress for progress reports and further strategizing with the final face-to-face meeting occurring in February 2020. Throughout this process, the Society of Critical Care Medicine standard operating procedures Manual for Guidelines development was adhered to.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Taskforce content experts separated into subgroups addressing pain/analgesia, sedation, tolerance/iatrogenic withdrawal, neuromuscular blockade, delirium, PICU environment (family presence and sleep hygiene), and early mobility. Subgroups created descriptive and actionable Population, Intervention, Comparison, and Outcome questions. An experienced medical information specialist developed search strategies to identify relevant literature between January 1990 and January 2020. Subgroups reviewed literature, determined quality of evidence, and formulated recommendations classified as "strong" with "we recommend" or "conditional" with "we suggest." Good practice statements were used when indirect evidence supported benefit with no or minimal risk. Evidence gaps were noted. Initial recommendations were reviewed by each subgroup and revised as deemed necessary prior to being disseminated for voting by the full taskforce. Individuals who had an overt or potential conflict of interest abstained from relevant votes. Expert opinion alone was not used in substitution for a lack of evidence.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The Pediatric Pain, Agitation, Neuromuscular Blockade, and Delirium in critically ill pediatric patients with consideration of the PICU Environment and Early Mobility taskforce issued 44 recommendations (14 strong and 30 conditional) and five good practice statements.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The current guidelines represent a comprehensive list of practical clinical recommendations for the assessment, prevention, and management of key aspects for the comprehensive critical care of infants and children. Main areas of focus included 1) need for the routine monitoring of pain, agitation, withdrawal, and delirium using validated tools, 2) enhanced use of protocolized sedation and analgesia, and 3) recognition of the importance of nonpharmacologic interventions for enhancing patient comfort and comprehensive care provision.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35119438/?utm_source=Other&utm_medium=rss&utm_content=1nASi37tjavWgzzNrvwbUd6RyLROfT7rZvRKQZB7qK8o1EeQ_7&ff=20220524175129&v=2.17.6">35119438</a> | DOI:<a href=https://doi.org/10.1097/PCC.0000000000002873>10.1097/PCC.0000000000002873</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35119438</guid>
      <pubDate>Fri, 04 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Heidi A B Smith</dc:creator>
      <dc:creator>James B Besunder</dc:creator>
      <dc:creator>Kristina A Betters</dc:creator>
      <dc:creator>Peter N Johnson</dc:creator>
      <dc:creator>Vijay Srinivasan</dc:creator>
      <dc:creator>Anne Stormorken</dc:creator>
      <dc:creator>Elizabeth Farrington</dc:creator>
      <dc:creator>Brenda Golianu</dc:creator>
      <dc:creator>Aaron J Godshall</dc:creator>
      <dc:creator>Larkin Acinelli</dc:creator>
      <dc:creator>Christina Almgren</dc:creator>
      <dc:creator>Christine H Bailey</dc:creator>
      <dc:creator>Jenny M Boyd</dc:creator>
      <dc:creator>Michael J Cisco</dc:creator>
      <dc:creator>Mihaela Damian</dc:creator>
      <dc:creator>Mary L deAlmeida</dc:creator>
      <dc:creator>James Fehr</dc:creator>
      <dc:creator>Kimberly E Fenton</dc:creator>
      <dc:creator>Frances Gilliland</dc:creator>
      <dc:creator>Mary Jo C Grant</dc:creator>
      <dc:creator>Joy Howell</dc:creator>
      <dc:creator>Cassandra A Ruggles</dc:creator>
      <dc:creator>Shari Simone</dc:creator>
      <dc:creator>Felice Su</dc:creator>
      <dc:creator>Janice E Sullivan</dc:creator>
      <dc:creator>Ken Tegtmeyer</dc:creator>
      <dc:creator>Chani Traube</dc:creator>
      <dc:creator>Stacey Williams</dc:creator>
      <dc:creator>John W Berkenbosch</dc:creator>
      <dc:date>2022-02-04</dc:date>
      <dc:source>Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies</dc:source>
      <dc:title>2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility</dc:title>
      <dc:identifier>pmid:35119438</dc:identifier>
      <dc:identifier>doi:10.1097/PCC.0000000000002873</dc:identifier>
    </item>
  </channel>
</rss>
